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v. Summary 
Voltage sensitive phosphatases: understanding their function 
and expanding their potential use 
Voltage sensitive phosphatases (VSPs) are proteins consisting of two distinct domains: 
a transmembrane voltage sensor domain (VSD) and a cytosolic phosphatase domain 
highly similar to the human tumor suppressor protein PTEN (phosphatase and tensin 
homologue deleted from chromosome 10). The first characterized VSP was isolated 
from the sea squirt Ciona Intestinalis, named Ci-VSP, one decade ago. Upon membrane 
depolarization, Ci-VSP has phosphatase activity against phosphoinositide (PI) 
substrates and acts predominantly as a 5-phosphatase of PI(4,5)P2 and PI(3,4,5)P3. 
VSPs exist in several species, including human, and although their function and 
physiological role are not completely understood, they have been proven excellent 
tools to rapidly and reversibly alter the phosphoinositide content of the plasma 
membrane in living cells. 
The first part of this work focuses on further characterizing and understanding the 
function of VSPs by using well established techniques. We used whole-cell patch 
clamping to control VSPs and total internal reflection fluorescent (TIRF) microscopy to 
record their activity.  
We first investigated the human VSP isoform 1 (hVSP1). hVSP1 lacks plasma membrane 
localization and has not been characterized in depth. Here we attempted to target 
hVSP1 to the plasma membrane and examine its enzymatic activity. We found that 
complete replacement of the VSD of hVSP1 with that of Ci-VSP resulted in a membrane 
targeted, voltage activated 5-phosphatase of PI(4,5)P2. 
Given the similarity of VSPs with PTEN, the chimeric protein PTENCiV had been created 
previously by fusing the VSD of Ci-VSP with PTEN. PTENCiV fully represents the 
enzymatic activity of PTEN (3-phosphatase of PI(3,4)P2 and PI(3,4,5)P3) and by being 
voltage regulated it comprises a powerful tool for studying this tumor suppressor. 
Specifically, we characterized the enzymatic activity of a novel PTEN mutation, A126G, 
identified from a prostate cancer patient. This mutation was found to convert the 
substrate specificity of PTEN from a 3- to a 5-phosphatase. 
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 VSPs are suggested to be involved in processes where pH and redox state changes are 
known to occur. Therefore we next investigated the effect of intracellular pH and 
redox state on VSPs activity. We saw that acidic pH increases the PI(4,5)P2 depletion by 
VSPs, while oxidation inhibits the enzymatic activity. Thus, it seems possible that pH 
and oxidation can, in addition to voltage, contribute to a fine modulation of VSPs. 
In the second part, we developed an easily applicable method to use VSPs for 
manipulation of PI levels without the use of patch clamping. We used different cation 
channels that upon activation led to membrane depolarization and consequently VSP 
activation. We then characterized methods to monitor PIs levels, using fluorescence 
microscopy or photometry. At last, we demonstrated the application of these 
techniques by employing PTENCiV to characterize the effect of known PTEN mutations 
and analyze the effect of PTEN inhibitors. 
In conclusion, in this work we increased our understanding regarding several aspects 
of VSPs activity, including hVSP1 and PTEN substrate specificity as well as the 
regulation of VSPs by intracellular pH and redox state. Lastly, we established an 
approach that allows for rapid manipulation and monitoring of PI levels in a population 
of cells and facilitates the study of PTEN mutations and pharmacological targeting. 
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vi. Zusammenfassung 
Spannungsempfindliche Phosphatasen: Verstehen ihrer 
Funktion und Ausweiten ihrer potenziellen Nutzung 
Spannungsempfindliche Phosphatasen (englisch: Voltage Sensitive Phosphatases, 
VSPs) sind Proteine, die aus zwei unterschiedlichen Teilen bestehen: einer 
transmembranen Spannungssensor-Domäne (VSD) und einer zytosolischen 
Phosphatase-Domäne. Die Spannungssensor-Domäne steuert die katalytische Aktivität 
einer Phosphatase, sehr ähnlich wie bei dem menschlichen Tumorsuppressorprotein 
PTEN (Phosphatase- und Tensin-Homolog gelöscht von Chromosom 10). Die erste 
charakterisierte VSP, Ci-VSP, wurde vor einem Jahrzehnt, von der Seescheide Ciona 
Intestinalis isoliert. Ci-VSP hat bei Membrandepolarisation eine Phosphatase-Aktivität 
gegenüber Phosphoinositid (PI) Substraten und sie wirkt vor allem als 5-Phosphatase 
von PI(4,5)P2 und PI(3,4,5)P3. 
VSPs wurden in verschiedenen Spezies gefunden, einschließlich dem Menschen. Trotz 
des fehlenden vollständigen Verständnisses, sind VSPs ausgezeichnete Werkzeuge, um 
den Phosphoinositid-Gehalt der Plasmamembran in lebenden Zellen schnell und 
reversibel zu ändern. 
Der erste Teil dieser Arbeit konzentriert sich auf die weitere Charakterisierung und das 
Verständnis der Funktion der VSPs mit Hilfe gut etablierter Techniken. Wir 
verwendeten die Whole-Cell-Patch-Clamp-Technik, um die VSPs zu kontrollieren und 
Interne Totalreflexionsfluoreszenzmikroskopie (englisch: Total Internal Reflection 
Fluorescence microscopy, TIRF) um ihre Aktivität aufzunehmen. 
Zuerst untersuchten wir die menschliche VSP-Isoform 1 (hVSP1). hVSP1 zeigt keine 
Plasmamembran-Lokalisation und deshalb ist es nicht tiefergehend charakterisiert 
worden. Hier haben wir versucht, hVSP1 an die Plasmamembran zu bringen und ihre 
enzymatische Aktivität zu untersuchen. Wir stellten fest, dass eine vollständige 
Ersetzung der Spannungssensor-Domäne von hVSP1 durch die von Ci-VSP eine 
membranständige, spannungsaktivierte 5-Phosphatase von PI(4,5)P2 ergibt. 
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Angesichts der Ähnlichkeit der VSPs mit PTEN wurde durch Verbindung der VSD von Ci-
VSP mit PTEN das chimärische Protein PTENCiV erstellt. PTENCiV, behält die vollständige 
enzymatische Aktivität von PTEN (PTEN wirkt als 3-Phosphatase von PI(3,4)P2 und 
PI(3,4,5)P3). Die zusätzliche Regulierbarkeit durch Spannung macht PTENCiV zu einem 
leistungsfähigen Werkzeug für die Untersuchung dieses Tumorsuppressors. 
Insbesondere haben wir die enzymatische Aktivität der neuen Prostatakrebs-PTEN-
Mutation A126G charakterisiert. Wir fanden heraus, dass die A126G-Mutante die 
Substratspezifität von PTEN von einer 3-zu einer 5-Phosphatase konvertiert. 
Es wird vermutet, dass VSPs in Prozessen, in denen pH- und Redox-
Zustandsänderungen auftreten, beteiligt sind. Deshalb untersuchten wir als Nächstes 
die Wirkung von intrazellulärem pH-Wert und von Redox-Zustand auf VSPs. Wir sahen, 
dass ein saurer pH-Wert den PI(4,5)P2 Abbau in allen getesteten VSPs erhöht, und dass 
Oxidation die enzymatische Aktivität von Ci-VSP hemmt. Es scheint daher möglich, dass 
zusätzlich zur Spannung auch pH-Wert und Oxidation zu einer feinen Modulation von 
VSPs beitragen. 
Im zweiten Teil entwickelten wir eine leichtanwendbare Methode zur Manipulation 
von PI-Pegeln -unter Verwendung von VSPs aber ohne die Notwendigkeit der Patch-
Clamp-Technik. Wir setzten verschiedene Kationenkanälen ein, die bei Aktivierung zu 
Membrandepolarisation führten und sequenziell zur VSP-Aktivierung. Als Nächstes 
charakterisierten wir Methoden um PI(4,5)P2 und PI(3,4,5)P3 unter Verwendung von 
Fluoreszenzmikroskopie oder Photometrie zu kontrollieren. Außerdem haben wir die 
Anwendbarkeit dieser Techniken gezeigt, um die Wirkung von bekannten PTEN-
Mutationen und PTEN-Inhibitoren durch Verwendung der PTENCiV Chimäre zu 
untersuchen.  
Als Ergebnis dieser Arbeit erhöhen wir das Verständnis über verschiedene Aspekte der 
VSP-Aktivität, einschließlich der Substrat Spezifität von hVSP1 und PTEN, sowie der 
Regulierung der VSP durch intrazellulären pH-Wert und Redox-Zustand. Außerdem 
haben wir einen Ansatz etabliert, der nicht nur zügige Manipulation und Kontrolle des 
PI-Gehalts in einer Population von Zellen zulässt, sondern der auch die Untersuchung 
von PTEN-Mutanten und Pharmakologie erleichtert. 
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1 Introduction 
1.1 Voltage sensitive phosphatases 
Voltage sensitive phosphatases are a family of enzymes presenting the unique feature 
of combining enzymatic activity and voltage sensitivity in a single protein. They consist 
of a voltage sensing domain (VSD), similar to those found in voltage-gated ion 
channels, linked to a phosphoinositides (PIs) phosphatase. The history of their 
discovery starts in 1999, when the first member of the VSP family was described; a 
putative transmembrane tyrosine phosphatase TPTE (transmembrane phosphatase 
with tensin homology, now termed hVSP2) cloned from human genome, 
demonstrating however no apparent phosphatase activity (Chen et al., 1999; Tapparel 
et al., 2003; Walker et al., 2001). Next members identified were a second human VSP 
protein, TPIP (TPTE and PTEN homologous Inositol lipid Phosphatase, also termed 
TPTE2 or hVSP1) and the murine VSP, mVSP (Walker et al., 2001; Wu et al., 2001). In 
contrast to hVSP2, these two VSPs displayed phosphoinositide phosphatase activity in 
in vitro phosphatase assays. However, the role of the transmembrane domain on the 
regulation of the phosphatase activity of the mammalian VSPs remained, and still 
remains, elusive. 
Six years later, light was shed on the VSPs field when Murata et al., 2005, for the first 
time, achieved to demonstrate how the voltage sensor domain was able to control the 
phosphatase activity (Fig. 1.2). They isolated the VSP of the ascidian Ciona intestinalis, 
Ci-VSP, and demonstrated in living cells that Ci-VSP was changing the concentration of 
PI(4,5)P2 in a manner that depends on the membrane potential. 
Soon VSPs from Danio rerio (Zebrafish), Xenopus laevis and Gallus gallus (chicken) 
were isolated and characterized (Hossain et al., 2008; Ratzan et al., 2011; Yamaguchi et 
al., 2014). The table 1 demonstrates all the up-to-date characterized VSPs. 
Extensive research substantially increased our understanding of three facets of VSPs’ 
function; a) the operation of the voltage sensor, meaning the movement and the 
conformational changes during activation (Villalba-Galea et al., 2008; Kohout et al., 
2008; Li et al., 2014), b) the electrochemical coupling, which describes the mechanism 
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through which the voltage sensor conveys the activation to the phosphatase (Kohout 
et al., 2010; Hobiger et al., 2012; Liu et al., 2012) and c) the enzymatic activity, mainly 
regarding the substrate specificity (Halaszovich et al., 2009; Matsuda et al., 2011; 
Kurokawa et al., 2012). 
 
 
Table 1: All characterized voltage sensitive phosphatases. References: 1, (Murata et al., 
2005); 2, (Halaszovich et al., 2012); 3, (Walker et al., 2001); 4, (Chen et al., 1999); 5, (Tapparel 
    Name             Species            Cellular             Tissue                 Predominant               Voltage       Citation 
                                                  localization     distribution                 activity                   activated        
Ci-VSP Ciona 
intestinalis 
PM sperm, 
neuronal 
tissue, blood 
5-phosphatase 
of 
PI(4,5)P2/PI(3,4,5)P3 
(in vivo) 
yes 1, 2 
hVSP1 
(4 isoforms) 
Human ER, Golgi testis, brain, 
stomach 
3-phosphatase 
of PI(3,4,5)P3  
(in vitro) 
not shown 3 
hVSP2 
(4 isoforms) 
Human ER, Golgi, 
PM 
testis, 
spermato-
cytes 
non not shown 4, 5 
Dr-VSP Danio rerio PM not shown 5-phosphatase 
of 
PI(4,5)P2/PI(3,4,5)P3 
(in vivo) 
yes 
 
6 
Xl-VSP 
(2 genes) 
Xenopus 
laevis 
PM testis, ovary, 
liver, kidney 
5-phosphatase 
of 
PI(4,5)P2/PI(3,4,5)P3 
(in vivo) 
yes 
 
7 
Gg-VSP Gallus 
gallus 
PM developing 
kidney 
5-phosphatase 
of 
PI(4,5)P2/PI(3,4,5)P3 
(in vivo) 
yes 
 
8, 9 
mVSP mouse Golgi Testis 3-phosphatase 
of 
PI(3,5)P2/PI(3,4,5)P3 
(in vitro) 
not shown 10 
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et al., 2003); 6, (Hossain et al., 2008), 7; (Ratzan et al., 2011); 8,(Neuhaus and Hollemann, 
2009); 9, (Yamaguchi et al., 2014); 10, (Wu et al., 2001). ER, endoplasmic reticulum; PM, 
plasma membrane. 
1.2 Phosphoinositides 
The substrate of VSPs, phosphoinositides (PIs), are phospholipids of the cellular 
membranes found in all eukaryotes. Although they are only a minor component of the 
membrane they play an important role in a variety of cellular processes including 
signaling, migration, proliferation, membrane trafficking and regulation of ion channels 
(Balla, 2013). They consist of a diacylglycerol (DAG) molecule linked to an inositol ring 
via a phosphodiester bond (Fig. 1.1A). 
 
Figure 1.1: Structure and metabolism of phosphoinositides. A: PIs consist of two fatty acid 
chains linked to an inositol ring. Phosphorylation of the ring at positions 3, 4 and 5 can 
generate the seven different PI species. B: Schematic representation of PIs and their 
interconversion by metabolizing enzymes. For simplicity, only the PIs and enzymes mentioned 
in this work are highlighted. Full arrows are demonstrating phosphatases and dashed arrows 
kinases. 
 
Phosphorylation of the inositol ring in several positions generates seven species of PIs, 
which demonstrate different membrane localizations and roles in cellular function 
(Table 2) (Falkenburger et al., 2010a; Devereaux and Di Paolo, 2013). A plethora of 
kinases and phosphatases strictly regulates the levels of each PI by interconversion 
between the different species (Fig. 1.1B). Impaired function of these metabolizing 
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enzymes has been connected to several diseases, including cancer, Lowe Syndrome, 
myopathies and many more (McCrea and De Camilli, 2009). 
 
Table 2: Different PIs, their cellular localization and their role in cellular function.  MVB, 
multivesicular bodies; ER, endoplasmic reticulum. 
1.3 Experimental control of phosphoinositides 
To further address their roles in cell biology, a number of experimental techniques has 
been developed to control PI levels in living cells. These techniques vary from 
pharmacological means and genetic manipulations, like overexpression or knock-down 
of PI metabolizing enzymes, to more dynamic approaches that allow temporal control 
over PI levels. There are three such techniques for acute PI manipulation available, all 
displaying certain limitations that need to be considered. 
The first technique is the FRB-FKBP (FK506 binding protein-fragment of mammalian 
target of rapamycin [mTOR] that binds FKBP) heterodimerization system that recruits a 
PI metabolizing enzyme (e.g., PI(4,5)P2 5-phosphatase) to the membrane by 
application of the drug rapamycin (Varnai et al., 2006; Suh et al., 2006). The timing of 
recruitment, which then results in e.g. acute PI(4,5)P2 depletion, can be precisely 
controlled. However, recruitment and hence the alteration of PI levels is irreversible. 
Furthermore, the use of the rapamycin-induced dimerization system is limited to cell 
types that do not express large amounts of FKBP or FRB protein domains endogenously 
(Coutinho-Budd et al., 2013). Additionally, unwanted effects via endogenous 
rapamycin targets have to be considered (Brown et al., 1994). 
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The second technique is also based on the acute recruitment of a 5-phosphatase to the 
membrane, this time by using the blue light-induced dimerization of CRY2-CIBN 
(cryptochrome 2- CRY2-interacting bHLH 1) domains (Idevall-Hagren et al., 2012). This 
system allows for PI(4,5)P2 depletion that is reversible within minutes, but imposes 
limitations on the analysis of PI levels using well established fluorescent biosensors, as 
the system is highly sensitive to blue and green light. 
A third strategy to manipulate PI levels in living cells utilizes VSPs. For example, Ci-VSP 
was used to study the PI-dependent regulation of ion channels (Yudin et al., 2011; 
Lindner et al., 2011). This approach allows for temporally precise, robust and quickly 
reversible changes in PI levels. However, it requires electrophysiological 
instrumentation, not available in many laboratories, and is time consuming since it 
only allows for single cell recordings. These limitations have restricted the broad use of 
VSPs as tools for manipulation of PIs. Part of this thesis will present a novel approach 
to overcome the above limitations and establish VSPs as an easy-to-use tool for 
controlling PI levels in living cells. 
1.4 Structure of VSPs 
Voltage sensitive phosphatases consist of a voltage sensor domain and a catalytic 
domain connected via a short amino acid sequence called the linker (Fig. 1.2). 
 
Figure 1.2: Schematic representation of a VSP.  VSPs comprise two distinct domains, the 
voltage sensor and the catalytic domain connected to each other by a short linker. The voltage 
sensor consists of four transmembrane helices, S1-S4, responsible for the activation by 
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membrane potential. S4 contains four positively charged amino acids (arginines) that act as 
sensing charges. Membrane depolarization changes the transmembrane electrical field and 
causes displacement of S4. The linker, also called PBM (PIP2 binding module), is an 
approximately 18 amino acids sequence rich in positively charged amino acids (arginines and 
lysines). These positively charged amino acids are shown to interact electrostatically with the 
negatively charged PI headgroups of the membrane, facilitating the transmission of the 
activation from the voltage sensor to the phosphatase domain. The catalytic domain consists 
of the phosphatase and C2 part (carboxyl-terminus). Here a 5-phosphatase activity against 
PI(4,5)P2 is illustrated as an example. 
 
Their voltage sensor domain consists of four transmembrane segments (S1-S4) with 
the fourth segment, S4, bearing four charged residues (arginines), which are 
responsible for the voltage sensing. Changes in the membrane potential can induce 
relocation of these charges and lead to conformational alternations in the protein 
itself. 
According to the crystal structure of Ci-VSP, the S4 undergoes an upward displacement 
and a rotation during activation (Li et al., 2014). This movement is facilitated by 
electrostatic interactions between the positive charges of S4 and the negatively 
charged amino acids of the S1 and S3 segments (Fig. 1.3A). 
The structure of the cytoplasmic region of the protein was solved by X-ray 
crystallography by Matsuda et al., 2011 and Liu et al., 2012 (Fig. 1.3B). It consists of 
two domains, the phosphatase domain and the carboxyl-terminus domain, C2. The 
phosphatase domain contains the protein-tyrosine phosphatases (PTP) signature 
motif, HCX5R (with X being any residue) located within a loop called the P 
(phosphatase binding)-loop. The P-loop along with two other elements, the TI 
(threonine/isoleucine)-loop and the WPD (tryprophane/proline/aspartic acid)-loop 
form the active site pocket of the phosphoinositide phosphatase. The C2 domain 
creates a hydrogen bond network with the phosphatase domain via its CBR3 (calcium 
binding region 3)-loop, although it does not appear to be actively involved in the 
catalysis. 
The linker domain plays a pivotal role in the VSP activity. It is considered responsible 
for the electrochemical coupling between the voltage sensor and the phosphatase 
domain. It consists of approximately 18 amino acids including several positive charged 
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residues that are suggested to facilitate the activation (Villalba-Galea et al., 2009; Liu 
et al., 2012; Hobiger et al., 2013). According to Hobiger's hypothesis the positive amino 
acids of the linker play two roles in the coupling process. First they interact 
electrostatically with the negatively charged PI headgroups of the plasma membrane 
recruiting the phosphatase domain closer to the membrane. Second they interact with 
the TI-loop of the active site and by neutralizing its negatively charged amino acids 
they facilitate the substrate binding.  
 
 
 
Figure 1.3: Structure of Ci-VSP. A: Mechanistic model of voltage sensing in Ci-VSP. During 
activation the S4 segment moves outwards and rotates by 60o. The arginines in S4 are 
stabilized by successive negative countercharges on S1 and S3. Modified from (Li et al., 2014). 
B: Schematic structure of the catalytic domain of Ci-VSP. The phosphatase domain consists of 
four β-strands surrounded by six α-helices. It contains the PI binding site which consists of 
three loop structures, the P-loop, the TI-loop and the WPD-loop. The C2 domain consists of 
nine β-strands and interacts with the phosphatase domain via its CBR3 loop. Image modified 
from (Matsuda et al., 2011). 
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1.5 Human VSPs 
In the human genome, two genes encode for proteins homologous to voltage sensitive 
phosphatases and they are named hVSP1 (originally termed TPIP or TPTE2) and hVSP2 
(originally termed TPTE) (Walker et al., 2001; Chen et al., 1999; Tapparel et al., 2003). 
hVSP1 which is expressed in testis, brain and stomach, presents phosphoinositide 
phosphatase activity in vitro (Walker et al., 2001). In contrast, hVSP2 that is found in 
testis lacks phosphatase activity probably due to amino acid exchanges in the catalytic 
motif of the P-loop (Chen et al., 1999). Various splice variants of hVSPs have been 
reported that mainly differ in the VSD (Fig. 1.4) (Tapparel et al., 2003). For hVSP1 there 
are four reported isoforms, all localizing at intracellular membranes, when tested in 
heterologous expression systems. hVSP2 also appears in four splice isoforms with 
three of them localized intracellularly and one isoform, hVSP2-3, localized at the 
plasma membrane. So far it has remained elusive whether these proteins are 
controlled via membrane depolarization.  
 
 
Figure 1.4: Human VSPs and their isoforms.  Schematic representations of hVSP splice 
isoforms derived from computational predictions performed by Tapparel et al., 2003. Four 
different isoforms have been isolated for hVSP1 and hVSP2. The isoforms mainly differ in the 
VSDs, either by lacking parts of the N-terminal part or by lacking entire transmembrane 
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segments. The different isoforms are often located in different cellular compartments. The 
dashed lines in the N-terminal part represent missing amino acids.  
1.6 Physiological role of VSPs 
The function of VSPs in vivo remains largely unknown but some hypotheses have been 
proposed concerning their role in physiological processes and possible mechanisms of 
their activation. As demonstrated in Table 1 VSPs are expressed not only in neuronal 
tissue, where regulation by voltage may be straightforward, but are also detected in 
non-neuronal tissue such as sperm, blood and kidney.  
In adult Ciona intestinalis for example, Ci-VSP is found in blood cells (Ogasawara et al., 
2011). Notably, in blood cells NADPH oxidase activity leads to cell membrane 
depolarization that could potentially activate Ci-VSP. 
In Xenopus, mRNA was found is several tissues predominantly in oocytes and sperm 
(Ratzan et al., 2011). Interestingly, the membrane potential of Xenopus eggs changes 
during fertilization from -20 to +20 mV, to block polyspermy. This voltage range is 
similar to the voltage range for activation of Xl-VSP1. The authors therefore 
hypothesise that the PI(4,5)P2 depletion by Xl-VSP inhibits cell membrane fusion, 
preventing this way the merging of an additional sperm to the oocyte. 
The chick ortholog Gg-VSP is expressed exclusively in the mesonephros during 
embryonic development and might be activated by transepithelial membrane potential 
(Neuhaus and Hollemann, 2009). Gg-VSP has also been suggested to regulate cell 
structure through the production of PI(3,4)P2 (Yamaguchi et al., 2014). 
The mammalian VSPs remain the most elusive. They are found in different tissues 
including sperm, brain, kidney, etc. (Table 1) but their physiological role is entirely 
unknown. Moreover it is unclear if they are voltage regulated and their substrate 
specificity has been only studied in vitro. 
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1.7 PTEN 
1.7.1 PTEN and disease 
PTEN is one of the most frequently mutated tumor suppressor proteins resulting in 
human cancer and other pathological conditions. Somatic PTEN mutations result in 
multiple sporadic tumor types, most frequently in the endometrium, central nervous 
system, skin and prostate (Chalhoub and Baker, 2009). Germline dominant mutations 
are related to hamartoma tumor syndromes, benign malformations predisposing for 
cancer (Hollander et al., 2011). More recently, the involvement of PTEN in neuronal 
activity and development has also been demonstrated, with PTEN germline mutations 
associated with autistic spectrum disorders (ASDs) (Garcia-Junco-Clemente and 
Golshani, 2014; Varga et al., 2009). 
PTEN exerts its tumor suppressor activity via direct antagonism of the 
phosphatidylinositol 3-kinase (PI3K) signaling pathway which regulates cell growth, 
survival, and proliferation. More specifically, by being a 3-phosphatase of PI(3,4,5)P3, 
PTEN counteracts the PI(3,4,5)P3 production via PI3K (Fig. 1.5).  
 
 
 
Figure 1.5: Simplified phosphatidylinositol 3-kinase (PI3K) signaling pathway.  PI3K 
phosphorylates PI(4,5)P2 to PI(3,4,5)P3. PI(3,4,5)P3 recruits AKT and its activator PDK1 to the 
membrane, where AKT will be activated by phosphorylation. AKT will then activate or 
deactivate several targets by phosphorylation, promoting cellular growth, survival and 
proliferation by various mechanisms. For simplicity, only some of the key players of the 
pathway are demonstrated. PTEN is the negative regulator of the PI3K signaling pathway since 
it directly antagonizes PI(3,4,5)P3 production by PI3K. Dashed lines represent indirect 
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interaction of AKT with protein targets. PI3K, phosphatidylinositol 3-kinase; AKT, protein kinase 
B; PDK1, phosphoinositide dependent kinase 1; mTOR, mammalian target of rapamycin; 
FOXO1, forkhead box 1. Schematic modified from (Chalhoub and Baker, 2009). 
 
The effect of mutations on PTEN activity has been assessed so far in vitro with 
phosphatase assays or in vivo with a yeast survival model. More specifically, in in vitro 
phosphatase assays, PTEN reacts with soluble or vesicle placed PIs, and the produced 
orthophosphate is measure using radioactivity or colorimetric assays (Lee et al., 1999; 
Maehama and Dixon, 1998). The yeast survival system is a non mammalian model, 
where PI3K and PTEN are coexpressed in S. Cerevisiae (Cid et al., 2008). PTEN 
phosphatase activity is assessed by its ability to counteract the toxic effect of a 
hyperactive form of PI3K, leading to cell survival.  
However, effects of PTEN mutations, in particular with respect to catalytic activity, 
cannot be addressed in the mammalian cell with the above techniques. The creation of 
the chimeric protein PTENCiV, previously from our laboratory, allowed for the first time 
examination of PTEN's catalytic activity in living mammalian cells (Lacroix et al., 2011). 
PTENCiV will be presented in detail in the following section. 
1.7.2 PTEN structure and PTENCiV 
VSPs are homologues of the tumor suppressor protein PTEN and their catalytic 
domains share substantial sequence similarity (Fig. 1.6A). As both, PTEN and the VSPs 
belong to the protein-tyrosine-phosphatase (PTP) super-family, they share the 
hallmark of the family, the HCX5R active site motif (Liu and Bankaitis, 2010). The active 
site HCX5R motifs within the P-loop of PTEN and Ci-VSPs are virtually identical apart 
from the fact that an alanine in PTEN is replaced by a glycine in the VSPs (Fig. 1.6B). 
Functionally, however, the two proteins are strikingly distinct: PTEN acts as a 3- 
phosphatase of PI(3,4)P2/PI(3,4,5)P3. In contrast Ci-VSP mainly acts as a 5-phosphatase 
of PI(4,5)P2/PI(3,4,5)P3 (Fig. 1.6C). 
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The crystal structures of the catalytic domain of Ci-VSP and PTEN also revealed a high 
degree of structural similarity with both proteins presenting the same architecture of 
phosphatase and C2 domains (Matsuda et al., 2011; Lee et al., 1999). The linker (or 
PBM) domain, although not included in the crystals, is also similar by sequence 
homology. There are only two main structural differences between PTEN and Ci-VSP. 
The first involves the position of TI-loop and the second the position of CBR3-loop 
(Matsuda et al., 2011). In particular, it is suggested that the TI-loop is located towards 
the active site pocket in Ci-VSP but not in PTEN, which may result in a bigger active site 
pocket in PTEN required for the accommodation PI(3,4,5)P3, PTEN’s predominate 
substrate. The second difference occurs in the CBR3-loop, which in Ci-VSP makes a 
contact with the WPD-loop whereas in PTEN it is considered to be involved in PTEN’s 
membrane association.  
 
Figure 1.6: Ci-VSP, PTEN and PTENCiV. A: Ci-VSP and PTEN demonstrate high sequence and 
structural similarity in their enzymatic domain. Fusion of PTEN with the VSD of Ci-VSP 
generated a chimeric protein that is activated by membrane depolarization while retaining the 
enzymatic properties of PTEN. PBM, PIP2 binding module; C-tail, the carboxyl-terminus domain; 
PDZ, domain binding motif, postsynaptic density protein–Drosophila disc large tumor 
suppressor–zonula occludens 1 protein. B: Part of the catalytic active site, called the P-loop, 
presents high sequence similarity between Ci-VSP and PTEN. C: Diagrammatic representation 
of the enzymatic specificity of Ci-VSP, PTEN and PTENCiV.  
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PTEN has a complex, not fully understood, mechanism of activation. Its N-terminal 
PBM site plays a role in membrane recruitment, in a similar manner as in Ci-VSP. 
However, the C-terminal part of PTEN, comprising the C-tail and the PDZ domain-
binding-motif (domains that are absent from Ci-VSP, Fig1.6A), is also involved in the 
regulation of the protein. Phosphorylation of the C-tail domain at several sites 
promotes an intramolecular interaction with the remainder of the molecule that 
regulates the membrane association and activity of PTEN (Rahdar et al., 2009). 
Moreover PDZ domain-containing proteins bind to PTEN's PZD domain-binding-motif 
and target it to the plasma membrane (Das et al., 2003).  
Recently, a chimeric protein was created by fusing the VSD of Ci-VSP with the entire 
PTEN protein. In that way, a membrane-localized, voltage-regulated PTEN, termed 
PTENCiV (Lacroix et al., 2011) was generated. This chimera displayed enzymatic activity 
in a strictly depolarization-dependent manner and fully recapitulated the catalytic 
activity of the wild type protein in being a 3-phosphatase of PI(3,4)P2/PI(3,4,5)P3 (Fig. 
1.6C). With its ability to switch enzymatic activity rapidly and reversibly in living 
mammalian cells, PTENCiV provided a novel approach for studying this important tumor 
suppressor. 
1.8 Experimental approaches to study VSPs 
The study of VSPs in living cells requires first a method to control them by using 
voltage and second a method to record their activity. For this reason, VSPs are 
primarily studied using electrophysiological methods on cell systems heterologously 
expressing the VSP of interest. For big host cells, such as Xenopus laevis oocytes, the 
two electrode voltage clamp is used while for smaller, mammalian cells the patch 
clamping approach is required. These electrophysiological methods allow for precise 
temporal control of the membrane potential and accordingly activation of VSPs. To 
record the activity of VSPs the experimenter can either directly monitor the electrical 
properties of the voltage sensor or monitor the phosphatase activity of the catalytic 
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domain as an effect of membrane depolarization. The following sections provide a 
detailed description of these two monitoring techniques.  
1.8.1 Measurement of sensing current  
The voltage sensing mechanism of VSPs closely resembles that of voltage gated 
channels (Villalba-Galea et al., 2008; Bezanilla, 2008). Changes in the membrane 
potential lead to movement of the positively charged S4 segment of the voltage sensor 
domain (Fig. 1.2). The fast movement of these charges within the membrane electrical 
field produces transient currents called sensing currents, as depicted in figure 1.7. 
Similar transient currents are generated also by voltage gated channels and are called 
gating currents since they regulate the opening of the channel's pore. When the 
voltage sensor moves to its active state, at depolarizing potentials, an outward 
transient current occurs called the “On” sensing current, while an inward transient 
current, the “Off” sensing current, occurs when the sensor returns to the resting 
position. 
 
Figure 1.7: VSPs' sensing currents.  Sensing currents are produced as a result of membrane 
depolarization and represent the movement of the S4 segment within the membrane electric 
field. Outward currents, called the “On” sensing currents, occur at depolarizing potentials, in 
cells kept at a holding potential of -80 mV. Return to the holding potential results in an inward, 
“Off”, current representing the returning of the sensor to its resting position. Modified from 
(Murata et al., 2005). 
 
The characteristics of sensing currents provide important information about the VSPs. 
For example the charge movement of the voltage sensor can be calculated by the time 
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integral of the sensing current. These sensing charges can be used to assess the 
expression levels of VSP in expression systems (Villalba-Galea et al., 2009). In addition, 
by measurement of the sensing charges over a range of voltages, with voltage step 
protocols as shown in figure 1.7, it is possible to derive the voltage dependence of the 
activation of VSD. Lastly, kinetic analysis of the decay rate of the “Off” currents can be 
used to assess the coupling of the voltage sensor to the phosphatase domain (Hobiger 
et al., 2012). 
1.8.2 Measurement of catalytic activity 
The enzymatic activity of VSPs can be studied dynamically in living cells by directly 
monitoring the changes of PIs levels as a result of VSPs activation. Two different 
approaches have been used to monitor PI level changes; PI(4,5)P2 sensitive K
+ channels 
and PI sensors.  
The use of K+ channels, such as KCNQ2/3 and Kir2.1, as reporters of the phosphatase 
activity is well established (Murata et al., 2005; Hossain et al., 2008; Liu et al., 2012; 
Sakata et al., 2011). These channels require PI(4,5)P2 for their function, therefore 
depletion of this phospholipid via VSPs results in decrease of the ionic current (Fig. 
1.8A,B). 
 
Figure 1.8: K+ channels for monitoring the catalytic activity of VSPs.  A: Schematic 
representation of a cell expressing Ci-VSP and a PI(4,5)P2 sensitive K
+ channel. Since these 
channels require PI(4,5)P2 for their activity, depletion of PI(4,5)P2 by Ci-VSP results in inhibition 
of the ionic current. B: In cells heterologously expressing KCNQ2/3 increasing voltage steps 
result in increasing ionic currents. In contrast, in cells coexpressing KCNQ2/3 and Ci-VSP the 
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ionic current decays at high potentials (red traces), indicating decreased PI(4,5)P2 levels. 
Modified from (Murata and Okamura, 2007).  
 
An alternative way to monitor VSPs enzymatic activity is by genetically encoded PI 
sensors and fluorescence microscopy (Várnai and Balla, 2006). PI sensors derive from 
proteins that physiologically bind to different phosphoinositides headgroups. One of 
the most extensively used are the pleckstrin homology (PH) domains isolated from 
several proteins and depending on the protein of origin, PH domains can specifically 
bind to certain PI species. Fusion of such domains with fluorescent proteins generates 
sensors that are able to report about concentration and localization of specific PI 
species. Table 2 lists the biosensors used in this work. 
 
 
Table 3: Biosensors used in this work. 
 
The use of these biosensors for assessing the catalytic activity of VSPs has been well 
established (Murata and Okamura, 2007; Halaszovich et al., 2009; Ratzan et al., 2011). 
As an example, we consider cells coexpressing Ci-VSP and a PI(4,5)P2 specific sensor 
(Fig.1.9A). At hyperpolarizing potentials Ci-VSP is inactive and the sensor is located 
mainly in the membrane where the PI(4,5)P2 concentration is high. Activation of Ci-VSP 
with membrane depolarization would result in PI(4,5)P2 depletion and therefore 
translocation of the sensor to the cytoplasm. This change in the membrane 
fluorescence can be recorded using confocal microscopy or more elegantly with total 
internal reflection fluorescence (TIRF) microscopy that specifically allows for 
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measurement of the plasma membrane fluorescence. An example of a patch clamping 
experiment, using Ci-VSP, PLCδ1-PH-GFP and TIRF microscopy is presented in figure 
1.9B.  
 
 
 
Figure 1.9: PI sensors for monitoring the catalytic activity of VSPs. A: Schematic 
representation of a cell expressing Ci-VSP and a PI(4,5)P2 specific sensor under whole cell patch 
clamp condition. Membrane depolarization results in activation of Ci-VSP, PI(4,5)P2 depletion 
and translocation of the biosensor (BS) to the cytosol. B: Time course graph of the TIRF 
microscopy signal from cells transfected with Ci-VSP and PLCδ1-PH-GFP, a PI(4,5)P2 specific 
biosensor. Activation of Ci-VSP at different depolarizing membrane potentials, causes 
depletion of PI(4,5)P2, translocation PLCδ1-PH-GFP to the cytosol and therefore decrease of the 
membrane fluorescence intensity. Modified from (Halaszovich et al., 2009). 
1.9 Aims of this work 
This work expands in two directions: first, to further our understanding of VSP function 
and second, to develop a simplified method for using VSPs as tool for experimental 
manipulation of PI concentrations. 
In the first section, we studied different aspects of VSPs and PTENCiV function and 
regulation that remained until now unknown, including substrate specificity, 
localization and dependence on intracellular conditions. More specifically, first we 
aimed at examining the substrate specificity of hVSP1, that was never been shown in 
living cells. Given the lack of plasma membrane localization of this protein, we initially 
focused on targeting it to the membrane by exchanging parts of it with VSPs that show 
strong plasma membrane localization, such as Ci-VSP and hVSP2. Second we focused 
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on characterizing a novel PTEN patient specific mutation by using the PTENCiV chimera. 
Interestingly this mutation, A126G, occurs in the highly conserved P-loop, part of the 
phosphatase's active site (Fig. 1.6B). The existence of a glycine in this position is 
however characteristic of 5-phosphatases such as Ci-VSP. Therefore, here we studied 
the effect of mutations in this position on the phosphatase activity and substrate 
specificity of PTENCiV. Third we investigated different modulators of VSPs' activity such 
as intracellular pH and redox state. pH changes are known to occur in processes such 
as sperm physiology, cell growth and migration. Although their exact physiological role 
in not yet fully understood, VSPs have been also suggested to be involved in the above 
mentioned processes. Here we compared the PIs' depletion rates caused by VSP 
activation under different intracellular pH values. We then accessed the effect of pH 
on the sensing of VSPs and in the kinetics of PI(4,5)P2 resynthesis. In addition we 
attempted to identify the amino acid that could act as the pH sensor by site directed 
mutagenesis of histidine residues of Dr-VSP. Lastly in this section, we systematically 
tested the effect of oxidation on Ci-VSP. 
All the above work was conducted by using whole-cell patch clamp technique for the 
control of the membrane potential and the subsequent activation of VSPs. This 
technique requires electrophysiological instrumentation and expertise as well as 
laborious single cell recordings. Thus, in the second section we aimed to simplify the 
manipulation of VSPs activation by developing a broadly applicable and 
electrophysiology-free approach. Such an approach could not only facilitate the study 
of VSPs but could also expand their use as phosphoinositide manipulation tools.  
To avoid electrophysiological methods we employed cation channels to induce 
membrane depolarization in a population of living cells. We compared different cation 
channels, i.e. constitutive open, ligand or light activated channels, for their ability to 
evoke VSPs activation. Different ways of monitoring VSPs activity by using 
fluorescence-tagged PI biosensors combined with standard microscopy or FRET 
(Förster Resonance Energy Transfer) were also studied. At last, having established the 
optimal conditions, we aimed at demonstrating the usefulness of this approach by 
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employing the PTENCiV chimera in order to study PTEN tumorigenic mutations and 
inhibitors, in a technically easy way, in a population of living cells. 
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2 Materials and Methods 
2.1 Molecular Biology 
Introduction of mutations into our expressing vectors was performed using the 
Quickchange II XL, Site-Directed mutagenesis kit (Agilent Technologies, Santa Clara, 
CA). Briefly, the technique was based on a polymerase chain reaction (PCR) using 
primers containing the desired mutation (biomers.net, Ulm, Germany). Template DNA 
was discarded by digestion (Dpn1, Thermo Scientific, Dreieich, Germany) and the PCR 
product was transformed in competent cells for DNA replication and purification. 
The general strategy for the creation of chimeric proteins was as follows; restriction 
sites were created with mutagenesis at the point of interest on the plasmids encoding 
for the two proteins. The plasmids were then digested with the appropriate enzymes 
(Thermo Scientific) and separated with electrophoresis based on their size. The 
selected DNA fragments were then fused using ligase (Thermo Scientific) and 
transformed in competent cells. For the final construct the restriction site was 
removed from the fusion site by mutagenesis. Lastly, the complete coding sequence of 
the construct was verified by sequencing (Seqlab, Gottingen, Germany). 
Specifically, the hVSP1hV2-3N chimera was constructed from amico acids 1-50 from 
hVSP2-3 and amino acids 71-522 from hVSP1. A KpnI restriction site was added at the 
site of fusion on the original plasmids. The hVSP1hV2-3V chimera was created by site-
directed mutagenesis on the hVSP1hV2-3N. That required substitution of eight amino 
acids located on the VSD of hVSP1hV2-3N. The hVSP1CiN was constructed from amino 
acids 1-123 from Ci-VSP and amino acids 82-522 from hVSP1. A schematic 
representation of these constructs can be found in the results part in figure 3.1. The 
hVSP1CiV and PTENCiV chimeras were created previously from colleagues as described in 
(Halaszovich et al., 2012) and (Lacroix et al., 2011) respectively.  
The Frubby construct was created by Dr. D. Schneider, from the Pippi-PI(4,5)P2 sensor 
(kindly provided from Dr. M. Matsuda, Japan (Yoshizaki et al., 2007)), by replacing the 
PLCδ1-PH domain with Tubby-Cterm protein. The AktAR construct was kindly provided 
from Dr. J. Zhang, Baltimore, USA (Gao and Zhang, 2008). 
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2.2 Cell culture and transfection 
The experiments were performed with human embryonic kidney 293 (HEK) cells and 
Chinese hamster ovary (CHO) cells. HEK cells were cultured in MEM Alpha medium 
containing 10% standard FBS, 1% penicillin-streptomycin 10.000 U/ml, 1% NEAA (100x) 
and 1% Na-Pyruvate (100x) (all chemicals were purchased from Gibco, Life 
Technologies). CHO cells were cultured in MEM Alpha medium containing 10% 
standard FBS, 1% penicillin-streptomycin 10.000 U/ml. For splitting and plating, the 
cells that had reached 80-90% confluency, were washed with PBS (1x) (Life 
Technologies) and incubated with Trypsin (1x) (Life Technologies) for 1-4 minutes for 
separation. The cells were then suspended in MEM Alpha medium for termination of 
the trypsinization process and then centrifuged for 2 min at 1200 rpm (Megafuge 2OR, 
Heraeus Instruments, Hanau, Germany). The pellet was then resuspended with 1 ml of 
fresh medium and distributed either in flasks for the continuation of the cell line or on 
glass cover slips (Thermo Scientific) and glass bottom dishes (WillCo Wells B.V., 
Amsterdam, The Netherlands) for experimental usage. A HERAcell 150i (Thermo 
Scientific) incubator was used to keep the cells at 37oC and at 5% CO2. 
24-48 hours after plating, the cells were transfected with expression vectors (cf.table 
4) using JetPEI (Polyplus Transfection, Illkrich, France), a linear polyethylenimine 
derivative, according to the manufacturer's instructions. PI(4,5)P2-3-kinase p110α 
(K227E) was cotransfected with PTENCiV to increase PI(3,4,5)P3 levels (Rodriguez-
Viciana et al., 1996). Before the start of the AktAR experiments, PI(3,4,5)P3 levels were 
elevated by incubating the cells with 0.4 ng/µl Insulin-like growth factor-1 for 15 
minutes (Halaszovich et al., 2009). HEK cells were preferred for confocal imaging, since 
they present a stronger membrane localization of PI markers. CHO cells were primarily 
used for patch clamp experiments. For patch clamping, single cells, with no contact to 
neighbor cells, are preferred. Since CHO cells form loose connections with each other, 
it is easy to remove neighbor cells by applying gentle suction through the patch 
clamping pipette. Experiments were performed 24-48 hours after transfection at room 
temperature. 
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                 Name                     UniProt accession No.    Amino acids               Vector                   Citation                   
Biosensors     
AktAR Chimeric construct  pcDNA3 1 
Akt1-PH P31749 1-164 pEGFP-N, pECFP-N, 
pEYFP-N 
2 
Btk-PH Q06187 1-177 pEGFP-N 3 
Frubby Chimeric construct  pCAGGS Dr. D. 
Schneider 
GRP1-PH O43739_2 261-381 pEGFP-C 4 
OSBP-PH P22059 88-188 pEGFP-N 5 
PLCδ1-PH P51178 1-170 pEGFP-N, pEYFP-C, 
pECFP-C 
6 
Tapp1-PH Q9HB21 182-303 pEYFP-C 7 
Tubby-Cterm P50586_2 243-505 pEGFP-C, pERFP-C 8 
Channels     
ChR2(H134R) B4Y105 Full length pEYFP 9 
KCNQ4 P56696 Full length pcDNA3.1 10 
Kir2.1 P35561 Full length pBK-CMV 11 
TASK3 Q9NPC2 Full length pcDNA3.1 12 
TRPV1 Q35433 Full length pEYFP-N 
(stop codon before 
YFP) 
13 
Enzymes     
Ci-VSP Q4W8A1 Full length pRFP-C, pECFP-C 14 
Dr-VSP B3IUN7 Full length pIRES-eGFP,  pIRES-
ΔeGFP 
15 
Xl-VSP1 Q4KLP3 Full length pRFP-C 16 
hVSP1 Q6XP53-3 Full length pRFP-C, pRFP-N 17 
hVSP2 P56180-3 Full length pEGFP-C 18 
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Table 4: List of the plasmids used in this study.   References: 1, (Gao and Zhang, 2008); 2, 
(Servant et al., 2000); 3, (Salim et al., 1996); 4, (Klarlund et al., 1997); 5, (Levine and Munro, 
1998); 6, (Várnai and Balla, 1998); 7,(Kimber et al., 2002); 8, (Santagata et al., 2001); 9, (Nagel 
et al., 2003); 10,(Chambard and Ashmore, 2005) 11, (Raab-Graham et al., 1994); 12, (Enyedi 
and Czirják, 2010); 13, (Caterina et al., 1997); 14, (Murata et al., 2005); 15, (Hossain et al., 
2008); 16, (Ratzan et al., 2011); 17,(Walker et al., 2001); 18, (Chen et al., 1999); 19, (Lacroix et 
al., 2011); 20, (Rodriguez-Viciana et al., 1996). 
2.3 Patch clamping 
2.3.1 Background 
Patch clamping is an electrophysiological method developed in 1976 by Neher and 
Sackmann (Neher and Sakmann, 1976) which enabled for the first time the 
measurement of single channel ionic currents. Since then, a number of different 
recording configurations have developed, allowing for the electrophysiological 
investigation of the behavior of single cells or whole cellular networks in the nervous 
system (Hamill et al., 1981). 
Here, we used the whole-cell configuration, which allows the electrophysiological 
study of intact cells. Since our primary aim here was to control the membrane 
potential, we used the voltage clamp mode in which, the membrane potential is 
controlled by the experimenter and the changes in the ionic current are recorded. As 
shown in figure 2.1A a glass pipette of a diameter not exciding 5 µm, was filled with a 
conducting salt solution, resembling the ionic composition of the intracellular solution. 
The pipette approaches the cell and with application of gentle suction the pipette tip 
will create a high resistance seal known as gigaseal, since it is usually in the range of 
Gigaohms. Application of a voltage pulse or/and suction will break the membrane 
patch and create a low-resistance access into the cell (Liem et al., 1995). 
hVSP1CiV Chimeric construct  pRFP-C O. Ebers 
PTENCiV Chimeric construct  pRFP-C 19 
PI3-kinase p110α 
(K227E) 
P32871 Full length pcDNA3.1 20 
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Figure 2.1: The whole-cell patch clamping technique.  A: Schematic representation of the 
whole-cell configuration. A pipette of small diameter needs to create a high resistance seal, 
gigaseal, with the cell membrane. Disruption of the seal with gentle suction or a voltage pulse 
opens the cell and provides access to the intracellular space. B: Simplified equivalent circuit for 
the whole-cell patch clamp configuration. A chlorided silver wire connects the cell interior to a 
feedback amplifier. Such an amplifier operates by calculating the difference between the 
command and the measured voltage and converting it to current. Vcom, command voltage; 
Rfeedback, feedback resistance; Cpip, pipette capacitance; Rleak, leak resistance; Rseries, series 
resistance; Cmem, membrane capacitance; Rmem, membrane resistance. Figures modified from 
(Liem et al., 1995; Molleman, 2003). 
 
Figure 2.1B depicts a simplified equivalent circuit of the whole-cell patch clamp 
configuration. A single chlorided silver electrode connects the intracellular 
compartment to a high resistance amplifier. Patch clamping amplifiers operate through 
a feedback system. The voltage set by the experimenter, Vcom, is compared to the 
measured membrane voltage. The difference between the set and measured 
membrane voltage is instantly corrected by current injection. This current, but of 
opposite sign, is the actual ionic current of the cell membrane. Several properties of 
the cell should be considered to acquire a precise patch clamp measurement. For 
example, the pipette and membrane capacitance, Cpip and Cmem, are compensated by 
internal electronic systems to prevent the appearance of capacitance currents. 
Another factor to be considered is the leak resistance, Rleak, introduced from the 
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membrane damage caused by the patching pipette. The Rleak needs to be high to 
increase cell viability and decrease voltage clamp errors. The series resistance, Rseries, 
represents the pipette and access resistance and also needs to be compensated to 
avoid voltage clamp errors.  
2.3.2 Patch clamping protocols 
Whole cell patch clamping was performed in CHO cells using an EPC-10 amplifier and 
PatchMaster software (both HEKA). Patch pipettes’ resistance was typically 1.5-4.0 
MΩ, recordings were sampled at 20 kHz and low-pass-filtered at 5 kHz. 
Sensing currents were recorded in response to test pulses between +40 mV and +180 
mV, from a holding potential of -70 mV. The increment of the voltage was 20 mV and 
the duration of the pulse was 200 ms. Linear leak and capacitive currents were 
subtracted using a P/N (positive/negative) protocol. 
In TIRF experiments hVSP1CiV was activated with membrane depolarization at +80 mV 
for 1 minute from a holding potential of -100 mV. PTENCiV was activated at + 80 mV for 
30 seconds from a holding potential of -60 mV. Ci-VSP, Dr-VSP and Xl-VSP1 were 
activated at different voltages, as indicated in the results part, for 30 seconds from a 
holding potential of -60 mV. 
In the experiments where Kir2.1 channels were coexpressed with Dr-VSP, Kir2.1 
currents were evoked by a 300 ms test pulse to -100 mV from a holding potential of      
-60 mV (Fig.2.2A). During the experiment, Dr-VSP was activated by membrane 
depolarization at different membrane potentials (Fig.2.2B red trace), resulting in 
depletion of PI(4,5)P2. Since Kir2.1 requires PI(4,5)P2 for its activity, activation of Dr-
VSP causes inhibition of the Kir2.1 currents as shown in the representative pulse traces 
(dashed boxes in figure 2.2B). To create the current-to-time trace (Fig.2.2B black 
trace), one Kir2.1 current measurement was recorded every 6 seconds. The data were 
next normalized to the baseline current prior to the activation of Dr-VSP (Fig.2.2C). 
For current clamp recordings of cells expressing ChR2, cells were held at 0 pA and 
changes of membrane voltage were recorded upon 1 second blue light exposure. 
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Figure 2.2: Protocol for Kir2.1/Dr-VSP measurements.  A: Current recorded from a CHO cell 
expressing Kir2.1 channel. Recordings were made at +100 mV from a holding potential of -60 
mV. B: Graph showing the current-to-time trace from a CHO cell coexpressing Kir2.1 channel 
with Dr-VSP. The current trace (black trace) was created from the Kir2.1 current value, 
recorded every 6 seconds. Since Kir2.1 is PI(4,5)P2 sensitive, activation of Dr-VSP at positive 
potentials inhibits the channel's activity, as shown in the representative Kir2.1 currents in the 
dashed boxes. The voltage protocol used for activation of Dr-VSP is shown in the red trace. C: 
For presentation, the current was normalized to the average current before the activation of 
Dr-VSP.  
2.4 Total Internal Reflection Fluorescence (TIRF) Microscopy 
TIRF microscopy (Axelrod, 1981; Fish, 2009) allows for recording fluorescence signals 
from the cell membrane and it is an ideally suited tool to monitor the spatial and 
temporal dynamics of fluorescent PI markers. Briefly, the excitation field of the TIRF 
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decreases exponentially with distance from the coverslip on which the sample is 
placed. Because of this decrease in the intensity the excitation field is also termed 
evanescent field (Fig. 2.3A). This allows for the excitation of fluorophores within 
approximately 100 nm from the coverslip-sample interface, minimizing therefore the 
detection of intracellular signals. 
 
Figure 2.3: TIRF microscopy function and measurements. A: The laser light passes first 
through immersion oil and then into a glass coverslip with equal refractive indexes, no=ng. Then 
the light exits the glass and encounters the interface with the sample. It changes direction 
because of the different refractive index of the sample, ns> ng. If the angle of incidence is 
greater than the “critical” ankle θc the light will not penetrate through the sample but it will be 
reflected. As a result an evanescent field is generated that allows for excitation of the 
fluorophores close to the plasma membrane. B: Laser light is guided through a mirror to the 
TIRF condenser which allows an easy adjustment of the laser beam to the correct illumination 
angle. The excitation light is then collected by a CCD (charged couple device) camera. A 
monochromator allows for simultaneous recordings of the epifluorescence signal from the 
sample. Modified from http://www.olympusmicro.com/primer/techniques/fluorescence/tirf 
/tirfintro.html. C: TIRF images of a CHO cell expressing Ci-VSP and the PI(4,5)P2 marker PLCδ1-
PH-GFP. A voltage jump from -60 to +80 mV leads to a decrease in the TIRF signal. Scale bar 10 
µm. D: Representative time course graph of the TIRF signal, deriving from an experiment as in 
panel C. 
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TIRF imaging was performed by using a Bx51WI upright microscope with a TIRF-
condenser (Olympus, Hamburg, Germany) and a 488 nm laser (Picarro, Sunnyvale, CA). 
The setup was equipped with a LUMPIan FI/IR 40x/0.8- numerical aperture water 
immersion objective (Olympus), an IMAGO-QE cooled CCD camera (TILL Photonics 
GmbH, Grafelfing, Germany) and a monochromator (Polychrome IV, TILL Photonics). A 
schematic representation of the setup is demonstrated in figure 2.3B. 
TIRF microscopy is an excellent tool for studying the PIs dynamics in living cells. Using 
fluorescent tagged PI biosensors, TIRF microscopy allows for monitoring changes of the 
PI levels at the plasma membrane, following VSP activation. Our setup combines TIRF 
microscopy with patch clamping instrumentation and facilitates simultaneous control 
of VSP activity and monitoring PI dynamics from the plasma membrane.  
As shown in figure 2.3C, a cell coexpressing a VSP and a PI(4,5)P2 specific biosensor is 
depolarized via the whole cell patch clamp method. This results in activation of the 
VSP, PI(4,5)P2 depletion and translocation of the biosensor from the plasma membrane 
to the cytosol and therefore decrease of the membrane fluorescence. The 
fluorescence was recorded from the “footprint”, of the cell, avoiding the cell edges, 
(Fig. 2.3C) and underwent background correction using TILLvision software. For the 
time course TIRF traces, fluorescent signal (F) was normalized to the baseline 
fluorescence prior to stimulation (F0), (Fig. 2.3D). 
2.5 Confocal Laser Scanning Microscopy 
The confocal laser scanning microscope allows for acquisition of high contrast and high 
resolution single plane fluorescent images. It is a powerful tool to investigate the 
localization and dynamics of fluorescently tagged molecules. A laser is used as light 
source providing a high power light beam able to be focused on a tight spot of the 
sample. The resolution of confocal microscopy is however limited due to diffraction of 
light. Depending on the excitation wavelength and the numerical aperture of the 
objective, the resolution can be in the range of hundreds of nanometers. The scanning 
ability of the microscope is achieved by scanning mirrors that change the angle of the 
laser beam allowing for a pixel-by-pixel image acquisition. The light emitted from the 
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sample passes through a pinhole, where the out of focus light is obstructed, creating 
therefore a single plane image (Fig. 2.4A). 
 
Figure 2.4: Confocal microscopy. A: Schematic diagram of the confocal microscope principle. A 
light beam generated by a laser is guided via a dichroich beam splitter to scanning mirrors. The 
scanning mirrors change the ankle of the laser beam allowing for a pixel-by-pixel image 
acquisition. In the next step the light emitted from the sample passes through a pinhole, 
where only the in focus light is allowed to pass, creating therefore a single plane image. In the 
last step, the light intensity is detected by a photodetection device which transforms the light 
signal into an electrical signal. B: Representative confocal images of CHO cells expressing Ci-
VSP-RFP and the PI(4,5)P2 biosensor tubbyC-GFP both located at the plasma membrane under 
resting conditions. Schematic in panel A modified from: http://www.zeiss.com/microscopy 
/ende/products/confocal-microscopes/confocal-microscopy- lsm-710.html 
 
Our setup consists of a Zeiss LSM710 Examiner upright microscope (Carl Zeiss AG; Jena; 
Germany) equipped with an argon multiline laser for excitation of YFP at 514 nm and 
GFP at 488 nm. A DPSS 561 nm laser line was used for RFP excitation and a 405 nm 
laser Diode was used for CFP excitation. For detection, wavelength ranges were 582-
754 nm for RFP and 493-582 nm for GPF. The objective used was a W-Plan-
Apochromat 20x1.0 DIC M27. The microscope is equipped with an HBO lamp with 
excitation bandpass filters 470/40 nm (blue) and 436/20 nm (violet). Confocal 
microscopy data acquisition was performed using ZEN2009 (Zeiss) software. 
We used confocal microscopy to determine the cellular localization of the different 
VSPs (Fig. 2.4B) or to acquire time series recordings of the biosensor's translocation 
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following activation of VSP. For the time series recordings, the fluorescence was 
averaged for regions in the cytosol (Fcyt) and normalized to the baseline fluorescence 
prior to stimulation (F0). 
2.6 Förster Resonance Energy Transfer (FRET) 
The phenomenon of FRET is based on the energy transfer between two fluorophores in 
close proximity to each other. Such an interaction occurs when the distance between 
the two molecules is smaller than ~20 nm. The use of FRET in microscopy involves a 
donor fluorophore, in our case CFP, that when excited can transfer its energy to the 
nearby acceptor fluorophore, here YFP, resulting in the acceptors excitation (Fig.2.5A). 
This can occur since the emission spectrum of CFP overlaps with the excitation 
spectrum of YFP (Fig. 2.5B). 
Here, widefield illumination FRET measurements were performed using a Nikon Eclipse 
TE2000-U inverted microscope equipped with a 40x0.55 LWD objective and coupled 
with an Oligochrome (TILL Photonics) light source. CFP and YFP were excited using a 
430/24 nm (F49-430, AHF Analysentechnik, Tubingen, Germany) filter and a 500/20 
nm (F49-500, AHF) filter respectively. Emission signal passed first through a tripleband 
beamsplitter CFP/YFP/mCherry (F68-017, AHF) and next detection area was selected 
using a viewfinder and a uEye camera (TILL Photonics). For CFP and YFP/FRET emission 
detection, a 470/23 nm (F49, AHF) and a 535/30 nm filter respectively, were placed in 
front of the photodiodes (TILL Photonics). Photodiode output signals were amplified by 
Oligochrome Imaging Control Unit (ICU). Next, these analog signals were acquired via 
the digital-analog converter integrated in the EPC-10 amplifier (HEKA electronics, 
Lambrecht, Germany). A simplified schematic representation of our setup is shown in 
figure 2.5C. Fluorescence intensity from a wide area including several cells -except for 
AktAR experiments, where fluorescence was collected from a single cell- was acquired 
and processed with PatchMaster software. FRET ratios, calculated as fFRET/fCFP, were 
normalized to the baseline before stimulation. fCFP and fFRET were the signals from 
the CFP and FRET emission channels, corrected for the dark current recorded without 
illumination.  
43 
 
 
Figure 2.5: The FRET approach.  A: When the two fluorophores are in distance from each other 
CFP excitation leads to normal 470 nm emission. Energy transfer between CFP and YFP only 
occurs when the fluorophores are in close proximity. At this case the energy from CFP emission 
is transferred to the YFP which emits at 535 nm. B: Excitation and emission spectra for CFP and 
YFP. The gray area represents the overlap between the CFP emission and the YFP excitation, 
which explains the phenomenon of energy transfer. C: Schematic representation of the FRET 
microscope setup used in this work. A filter based light source (Oligochrome) was used for 
sample excitation. The emission light first passed through a triple band beam splitter and then 
through a view finder camera for cell selection. To achieve dual emission detection, CFP/YFP 
beam splitter was placed before the detectors. Lastly, the signal was delivered to an imaging 
control unit (ICU) for conditioning and to an amplifier for analysis and storage.  
2.7 Solutions and chemicals 
In most experiments, cells were kept in extracellular solution containing (mM) 144 
NaCl, 5.8 KCl, 0.9 MgCl2, 1.3 CaCl2, 0.7 NaH2PO4, 5.6 D-glucose, and 10 HEPES, pH 7.4 
(with NaOH) 305-310 mosm/kg (standard extracellular solution). Solutions with 
increased K+ concentration were made by replacing NaCl with KCl. For maximal 
depolarization, a 150 mM K+ solution was required prepared as follows (mM): 150 KCl, 
0.9 MgCl2, 1.3 CaCl2, 0.7 NaH2PO4, 5.6 D-glucose, and 10 HEPES, pH 7.4 (with KOH).  
For the TRPV1 and ChR2(H134R) experiments Ca2+ was omitted from the standard 
extracellular solution to prevent the Ca2+ dependent activation of phospholipases (PLC) 
(Ca2+-free extracellular solution) (Rebecchi and Pentyala, 2000). 
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For experiments combining patch clamping and TIRF imaging cells were kept in 
standard extracellular solution while the intracellular solution in the patch pipette 
contained (mM) 135 KCl, 2.41 CaCl2, 2.5 MgCl2, 5 EGTA, 5 HEPES and 3 Na2-ATP, pH 7.3 
(with KOH), 290-295 mosm/kg. 
For experiments where the sensing currents were measured, we used solutions lacking 
K+ and Na+ to minimize the ionic currents. The extracellular solution contained (mM): 
75 NMDG, 80 HEPES, 1 CaCl2, 1 MgCl2 and glucose 10mM, pH 7.5 (with 
methanesulfonic acid), 305-310 mosm/kg. For the intracellular solution we used (mM): 
65 NMDG, 3 MgCl2, 1 EGTA, 100 HEPES, pH 7.5 (with methanesulfonic acid), 290-295 
mosm/kg. 
Capsaicin, IGF1 and glutathione disulfide (GSSG) were purchased from Sigma-Aldrich 
(St.Louis, Missouri), the Bisperoxovanadate compounds from Santa Cruz Biotechnology 
(Dallas,TX), DTT from Fermentas (St. Leon-Rot, Germany) and H2O2 from Calbiochem 
(Billerica, Massachusetts).  
2.8 Data analysis 
To determine the kinetics of the sensing currents' decay and of the PI(4,5)P2 recovery, 
we calculated the time constants τ by fitting the acquired data to the exponential 
function described in figure 2.6A. The charge movement Q was calculated by time 
integration of the sensing current (Fig.2.6B). For the voltage dependence of Kir2.1 
currents, the data were fitted to the Boltzmann equation to calculate the voltage for 
half maximal current inhibition (V1/2) (Fig.2.6C). For the capsaicin concentration-
response curve, data were fitted to the Hill equation to calculate the half maximal 
effective concentration (EC50) (Fig.2.6D).  
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Figure 2.6: Data calculation and curve fitting.  A: To calculate the time constant of the sensing 
current decay or the time constant of the PI(4,5)P2 resynthesis the curves were fitted to a 
single exponential equation. B: The charge movement was calculated by time integration of 
the “On” sensing current. C: To calculate the V1/2 (x1/2 in the figure) of Kir2.1 channels inhibition 
the curve was fitted to the Boltzmann (Sigmoid) equation. D: To estimate the EC50 (x1/2 in the 
figure) of the capsaicin induced activation we fitted the curve to the Hill equation. 
 
To calculate the maximal response to K+ or capsaicin, values acquired during the last 30 
seconds of the application were averaged. For ChR2-mediated Ci-VSP activation, the 
maximal response represents the first value acquired after the blue light exposure. To 
estimate which cation channel led to the fastest response we calculated the time 
required to reach 50% of the maximal response (t1/2 initiation), for each individual cell. 
For ChR2 analysis, we utilized the blue light exposure time curve (Fig. 3.12I) to 
calculate the time required for fluorescence intensity to reach 50% of its maximal 
value. For recovery kinetics, the time required to reach 50% of the baseline after the 
end of the application was calculated (t1/2 recovery). Only cells that demonstrated a 
fluorescence intensity change greater than 4% upon application of the substance were 
used for the analysis. 
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Error bars show the S.E.M, n represents the number of cells and e represents the 
number of experiments. For statistical analysis, a two-tailed Dunnett’s test was 
performed to compare the control to different experimental groups, a Student’s T-test 
was used to compare two groups and a Scheffe’s test for multiple comparisons. 
Statistical significance was assigned at P<0.05 and is marked as * for the Dunnett’s and 
Scheffe’s test and as # for the Student’s T-test. IgorPro (Wavemetrics, Lake 
Oswego,OR) software was used for data analysis and presentation. 
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3 Results 
3.1 Functional characterization of VSPs 
The first part of the results involves the study of several aspects of VSP function such 
as substrate specificity, subcellular localization and dependence on pH and redox state. 
VSPs were activated via whole-cell patch clamping and the phosphatase activity was 
monitored using TIRF microscopy of fluorescent-tagged PI biosensors. 
3.1.1 Generation of a functional human VSP chimera targeted to the 
plasma membrane 
Although VSPs have been isolated from the human genome several years ago (Chen et 
al., 1999; Tapparel et al., 2003; Walker et al., 2001), the mechanism of their activation 
remains up to now elusive. In vitro phosphatase assays suggested that hVSP1 acts as a 
3-phosphatase of PI(3,4,5)P3, while hVSP2 lacks phosphatase activity. However, 
regulation of hVSP1 by membrane voltage has not been demonstrated so far because 
all the splice variants (Fig.1.4) are localized in intracellular membranes, when 
expressed in heterologous expression systems. On the other hand, splice variants of 
the catalytically inactive hVSP2 show distinct cellular localization, with the hVSP2-3 
isoform located in the plasma membrane. The different splice variants of hVSP1 and 
hVSP2 mainly differ in the length of the cytoplasmic N-terminus. 
Here we attempted to target hVSP1 to the plasma membrane and examine whether its 
enzymatic activity is controlled by the voltage sensor domain. Overexpression of mRFP 
tagged hVSP1-1 in CHO cells was restricted to intracellular compartments, as revealed 
by confocal microscopy, consistent with previous observations (Walker et al., 2001; 
Tapparel et al., 2003). This subcellular localization was independent of the position of 
the mRFP tag (Fig. 3.1A, B). 
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Figure 3.1: Cellular localization and sensing currents of wild type and chimeric VSPs.  A and B: 
hVSP1 is located in intracellular compartments. C: hVSP2-3 is the only hVSP2 isoform localizing 
at the plasma membrane. D and E: Chimeric proteins fusing the N-terminus (D) or the VSD (E) 
of hVSP2-3 with hVSP1 demonstrated no plasma membrane localization and no sensing 
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currents. F: Membrane localization of Ci-VSP. G: The chimeric protein hVSP1CiN presenting 
intracellular localization and no sensing currents. H: hVSP1CiV demonstrated membrane 
localization and sensing currents. Scale bar 10 µm. 
 
Given the fact that hVSP2-3 splice variant is located at the plasma membrane (Fig.3.1C) 
we considered a possible role of the cytoplasmic N-terminus in membrane targeting. 
Therefore, we first created a chimeric protein substituting the N-terminus of hVSP1 
with the N-terminus of hVSP2-3, named hVSP1hV2-3N (Fig. 3.1D). hVSP1hV2-3N did not 
succeed in reaching the plasma membrane and presented no electrical activity in the 
form of sensing currents. 
The second chimeric protein created, named hVSP1hV2-3V, consists of the entire voltage 
sensor of hVSP2-3 and the phosphatase domain of hVSP1 (Fig. 3.1E). This construct 
also presented no detectable plasma membrane localization and no sensing currents. 
Next we thought of utilizing the Ci-VSP N-terminus and VSD since this VSP is strongly 
localized to the plasma membrane and generates robust sensing currents easily 
detected with patch clamping (Fig. 3.1F). We followed the same approach as 
previously and exchanged the N-terminus of hVSP1 with the N-terminus of Ci-VSP, 
creating a chimeric protein named hVSP1CiN (Fig. 3.1G). This chimera also failed to 
reach the plasma membrane. The only hVSP1 chimera that reached the membrane and 
generated sensing currents was created by exchanging the entire voltage sensor 
domain of hVSP1 with the voltage sensor of Ci-VSP, named hVSP1CiV (the specific 
construct was created by O. Ebers)(Fig. 3.1H). 
Since hVSP1CiV was the only chimera targeted to the membrane, we proceeded by 
testing its lipid phosphatase activity in living cells, using patch clamping combined with 
TIRF microscopy. In CHO cells coexpressing hVSP1CiV and the PI(4,5)P2 sensor PLCδ1-PH-
GFP (Várnai and Balla, 1998) depolarization of the membrane potential resulted in 
decrease of the fluorescent signal signifying PI(4,5)P2 depletion (Fig. 3.2A). As a control 
experiment, we transfected the catalytic inactive (dead) hVSP1 mutant C363S, in order 
to show that the fluorescence decrease really results from the phosphatase activity of 
the protein. The specific mutation is known to inactivate all VSP homologues because 
it disables the catalytic mechanism of the phosphatase. Indeed, cells transfected with 
the catalytically “dead” hVSP1 demonstrated no decrease in the fluorescence intensity 
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(Fig. 3.2A). To assess if the dephosphorylation occurs at the 4- or 5-phosphate of 
PI(4,5)P2, hVSP1CiV was cotransfected with the PI(4)P sensor OSBP-PH-GFP (Levine and 
Munro, 1998). Activation of hVSP1CiV by depolarization resulted in an increase of the 
membrane fluorescence indicating increase of the PI(4)P concentration. This finding 
suggests that the hVSP1CiV acts as a 5-phosphatase of PI(4,5)P2 (Fig. 3.2B). Lastly, when 
the PI(3,4)P2 sensor TAPP1 (Kimber et al., 2002) was used, an increase of the 
fluorescence was observed, suggesting that hVSP1CiV acts also as a 5-phosphatase of 
PI(3,4,5)P3 (Fig. 3.2C). 
As a conclusion, our results suggest that hVSP1 is a functional phosphatase that can be 
activated via an N-terminal voltage sensor and despite of what was previously 
believed, hVSP1 acts as a 5-phosphatase of PI(4,5)P2 and PI(3,4,5)P3. 
 
Figure 3.2: Enzymatic activity of hVSP1CiV.  A: TIRF signals of CHO cells expressing hVSP1CiV and 
the PI(4,5)P2 sensor PLCδ1-PH-GFP. Membrane depolarization leads to activation of the 
phosphatase, PI(4,5)P2 depletion and PLCδ1-PH-GFP translocation (n=7). No decrease in the 
fluorescent signal is observed with the catalytically dead mutant C363S (n=4). B: TIRF signal of 
cells expressing hVSP1CiV and the PI(4)P sensor OSBP-PH-GFP. Activation of the phosphatase 
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leads to an increase of the fluorescent signal indicating PI(4)P production. C: When the 
PI(3,4)P2 sensor TAPP1 was coexpressed with hVSP1CiV, an increase of the fluorescence was 
observed, suggesting that hVSP1CiV dephosphorylates PI(3,4,5)P3 in the 5 position. The image is 
modified from (Halaszovich et al., 2012) and experiments were performed by Dr. Michael 
Leitner. 
3.1.2 Functional characterization of a novel PTEN oncogenic mutation 
PTEN is one of the most frequently mutated tumor suppressors in human cancer and 
other pathological conditions. It exerts its tumor suppressor activity via direct 
antagonism of the phosphatidylinositol 3-kinase (PI3K) signaling pathway by 
counteracting the PI(3,4,5)P3 production via PI3K (Fig. 1.5). PTEN displays remarkable 
structural and functional similarity with VSPs. This enabled the development of the 
chimeric protein PTENCiV, which fully reproduced the substrate specificity of wild-type 
PTEN and could be activated by membrane depolarization, provided a novel approach 
for controlling the activity of PTEN and studying this important tumor suppressor 
(Lacroix et al., 2011). 
Here we use this approach to characterize the enzymatic activity of a novel PTEN 
mutation identified from a prostate cancer sample (Costa et al., 2015). The mutation 
occurred at position 126 where the original alanine was mutated to a glycine. Alanine 
126 is located within the highly conserved HCX5R motif, in the catalytic P-loop site of 
PTEN. Interestingly, this A126G mutation produces an amino acid sequence identical to 
VSP family proteins. Functionally, PTEN is a 3-phosphatase, whereas Ci-VSP primarily 
acts as a 5-phosphatase of PI(4,5)P2/PI(3,4,5)P3 (Fig. 3.3A). We therefore hypothesized 
that the A126G mutant could convert the substrate specificity of PTEN from a 3- to a 5- 
phosphatase.  
We used whole-cell patch clamping for activation of PTENCiV and TIRF microscopy to 
investigate the effect of this oncogenic mutation on the phosphatase activity of PTEN. 
When A126G PTENCiV was coexpressed with the PI(3,4,5)P3 specific domain Btk-PH-GFP 
(Salim et al., 1996), activation of A126G PTENCiV resulted in a decrease of the 
membrane fluorescence, indicating that the mutant retains phosphatase activity 
against PI(3,4,5)P3 (Fig. 3.3B). The WT PTENCiV showed also a decrease in the 
fluorescence signal, signifying the PI(3,4,5)P3 depletion. 
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Figure 3.3: The PTEN A126G oncogenic mutant is causing a gain of function. A: Amino acid 
sequence comparison of the HCX5R motif, in the active site region of PTEN and Ci-VSP. Within 
the P-loop the only amino acid that differs is the alanine 126. B: Time course of TIRF signals 
from cells coexpressing the PI(3,4,5)P3 specific domain Btk-PH-GFP with WT, A126G, or the 
catalytically inactive C124S PTENCiV. PTENCiV was activated at +80 mV for 30 seconds from a 
holding potential of -60 mV. The decrease of the fluorescent signal represents the depletion of 
PI(3,4,5)P3. C: Time course of TIRF signals from cells coexpressing the PI(3,4)P2 specific domain 
TAPP1-PH with WT, A126G, or the catalytically inactive C124S PTENCiV. WT PTENCiV results in a 
decrease in the TIRF signal meaning depletion of PI(3,4)P2. In contrast the A126G mutant 
demonstrates an increase of fluorescence signal indicating an increase in the PI(3,4)P2 
concentration. D and E: Summary data of phosphatase activity of several PTEN oncogenic 
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mutants at the position A126. Experiments were performed as in panels B and C with 
fluorescence being measured at the end of the depolarization step. In D, the oncogenic 
mutants A126P and A126V demonstrate complete loss of enzymatic activity while the mutants 
A126G, A126S and A126D demonstrate decreased activity compared to the WT PTENCiV. In 
panel E, only the A126G mutation causes an increase of fluorescence signal. At least 7 cells per 
mutant were measured. Graphs B-E were modified from (Costa et al., 2015). TIRF 
measurements for A126G, A126P and A126V were performed by Dr. M. Leitner. 
 
For control, we transfected with the catalytically inactive (dead) mutant C124S. The 
specific mutation in known to inhibit the catalytic mechanism of PTEN and of VSPs, 
resulting in inactive phosphatases. As shown in Figure 3.3B, no decrease in the 
fluorescence intensity was observed for C124S PTENCiV. However, when the PI(3,4)P2 
specific domain TAPP1-PH was coexpressed with A126G PTENCiV, a robust increase in 
the fluorescent signal was observed (Fig. 3.3C). This increase in PI(3,4)P2 levels 
suggests that A126G PTENCiV indeed acts as a 5-phosphatase of PI(3,4,5)P3, consistent 
with our original speculation. 
Moreover, to examine if this swift in the phosphatase specificity is an exclusive feature 
of the A126G mutant, we extended this approach to further oncogenic somatic 
mutations reported in COSMIC (Catalogue of Somatic Mutations in Cancer 
(http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/). We mutated alanine in 
position 126 to proline, valine, aspartic acid and serine and performed experiments as 
described in panels B and C. Coexpression of the mutants with the PI(3,4,5)P3 specific 
domain Btk-PH- GFP (Fig. 3.3D), revealed no or decreased phosphatase activity. When 
the PI(3,4)P2 specific domain TAPP1-PH was used, none of the mutants presented an 
increase of fluorescence signal (Fig. 3.3E) and therefore no swift in the specificity.  
In conclusion, we showed that alanine to glycine exchange at the position 126 in the 
HCX5R motif, converted the specificity of PTEN from a 3-phosphatase to a 5-
phosphatase of PI(3,4,5)P3. 
3.1.3 The effect of intracellular pH and redox state on VSPs 
Although little is known about the physiological role of VSPs, it has been hypothesized 
that they have a function in sperm physiology and fertilization, cell morphology, 
growth and development, (Murata et al., 2005; Ratzan et al., 2011; Yamaguchi et al., 
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2014; Neuhaus and Hollemann, 2009). However, it is not really clear, if the voltage 
changes that occur in these cells types are sufficient for activating VSPs, given their 
relatively positive range of activation. Therefore it was an obvious undertaking to 
search for additional activating stimuli and conditions.  
Sperm physiology and fertilization are known to be influenced by intracellular pH and 
redox state changes (Nishigaki et al., 2014; Zeng et al., 1996; Baltz et al., 1995; Aitken 
et al., 1995; de Lamirande and O’Flaherty, 2008). In addition, changes in the 
intracellular pH are shown to be important in cell polarity and migration (Casey et al., 
2010). Thus, in this part we are investigating the effect of intracellular pH and redox 
state on VSPs activity. 
3.1.3.1 Acidic intracellular pH increases the PI(4,5)P2 but not the PI(3,4,5)P3 
depletion by VPSs 
To study the effect of pH, we performed whole-cell patch clamp experiments with 
intracellular solutions of different pH values (pHint). CHO cells were transfected with 
the VSP isolated from zebrafish, named Dr-VSP, and the PI(4,5)P2 sensor PLCδ1-PH-GFP. 
We found that at acidic pHint, the PI(4,5)P2 depletion was more pronounced compared 
to neutral or alkaline pHint (Fig. 3.4A). To exclude that this pH effect resulted as an 
artifact from pH sensitivity of GFP or the binding affinity of the biosensor, we chose an 
additional, independent method to monitor Dr-VSP activity. The inward rectifier K+ 
channel Kir2.1 has already been used as a readout of VSP activity as it is highly 
sensitive to PI(4,5)P2 depletion (Liu et al., 2012; Sakata et al., 2011). Moreover Kir2.1 is 
insensitive to pH changes in the range used here (Qu et al., 2000). Activity of Kir2.1 was 
monitored as the inward current during a step voltage pulse to -100 mV from a holding 
potential of -60 mV. Activation of Dr-VSP with membrane depolarization inhibited the 
Kir2.1 currents as shown in figure 3.4B. The degree of current inhibition was higher 
when pHint 6.4 was used compared to pHint 7.3, indicating that the PI(4,5)P2 depletion 
was stronger under acidic intracellular conditions. The voltage dependence of the 
current inhibition – and hence activity of Dr-VSP - was shifted towards more negative 
potentials when pHint 6.4 was used (Fig. 3.4C). Specifically, the V1/2 for pHint 6.4 was 
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estimated 44 ± 4.3 mV while for pHint 7.3 the V1/2 was 59 ± 15 mV as calculated from 
fitting the Boltzmann equation to the measurements.  
 
Figure 3.4: Increased PI(4,5)P2 depletion at acidic pH with Dr-VSP.  A: TIRF signals from cells 
expressing Dr-VSP and the PI(4,5)P2 sensor PLCδ1-PH-GFP. Increased PI(4,5)P2 depletion is 
observed at acidic PHint (e=18 for pHint 8.3, e=19 for pHint 7.3 and e=20 for pHint 6.4). B: 
Normalized currents in cells coexpressing the K+ channel Kir2.1 and the Dr-VSP. Here, the 
inward currents at -100 mV from a holding potential of -60 mV were measured. Kir2.1 channels 
were inhibited by Dr-VSP mediated PI(4,5)P2 depletion. Dr-VSP was activated by depolarizing 
voltage pulses to 0, +20, +40, +60 and +80 mV. Stronger inhibition is observed under acid 
intracellular conditions, indicating potential increased Dr-VSP activity (e=7 for pHint 7.3 and e=8 
for pHint 6.4). C: Voltage-current inhibition curve for Kir2.1 estimated by plotting the current 
value at the end of each voltage application from graph B. The use of pHint 6.4 caused a shift of 
the curve towards more negative potentials. 
 
The pH sensitivity observed above is not restricted to Dr-VSP but was also apparent in 
VSP from other species, such as in Ci-VSP and the Xenopus laevis VSP, Xl-VSP1. TIRF 
experiments as in figure 3.4A were performed for Ci-VSP and Xl-VSP1 and similar 
results were obtained, with acidic pH to increase the degree of PI(4,5)P2 depletion. To 
present the data, the fluorescence time course traces were normalized to the 
fluorescence value prior to VSP activation and then plotted against voltage (Fig. 3.5). 
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Figure 3.5: Other VSPs present similar sensitivity to pH.  Graphs representing the TIRF signals 
from cells expressing Dr-VSP, Ci-VSP or Xl-VSP1 with the PI(4,5)P2 sensor PLCδ1-PH-GFP. The 
values for these graphs derive from time series experiments as in figure 3.4A, plotted against 
voltage. For Dr-VSP the values derive from graph 3.4A. At least 7 cells for each pH value were 
measured. 
 
To study if this pH sensitivity is also apparent with PI(3,4,5)P3 as a VSP substrate, Dr-
VSP was coexpressed with the Btk-PH-GFP domain, a PI(3,4,5)P3 specific sensor. In 
contrast to dephosphorylation of PI(4,5)P2, TIRF experiments revealed no pH sensitivity 
of PI(3,4,5)P3 depletion by Dr-VSP (Fig. 3.6). 
 
Figure 3.6: Intracellular pH does not affect the PI(3,4,5)3 depletion via Dr-VSP.  Here the Btk-
PH-GFP sensor was used to monitor PI(3,4,5)3 levels. Different intracellular pH values did not 
change the degree of PI(3,4,5)P3 depletion after activation of Dr-VSP at +40 and +80 mV. e=8 at 
pHint 6.4, e=8 at pHint 7.3, e=8 at pHint 8.3. 
3.1.3.2 pH does not affect the voltage dependence of VSP sensing  
Since VSPs consist of two distinct domains, the voltage sensor domain and the catalytic 
domain, we asked if the increased PI(4,5)P2 depletion observed at acidic intracellular 
pH can be explained by a shift in the voltage dependence of the sensing (gating). 
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According to this hypothesis, at acidic pH more VSDs would be at the “On” 
conformation at a certain voltage. This could potentially be the explanation for the 
increased PI(4,5)P2 depletion at acidic pH. To test this hypothesis we calculated the 
charge movement from the “On” sensing current of Dr-VSP, during a stepwise increase 
of the membrane potential (Fig. 3.7A, B). We observed no significant differences in the 
voltage dependence of the sensing currents under different intracellular pH values. In 
particular the V1/2 at pHint 6.5 was 98.15 ± 4.9 mV, for pHint 7.5 was 106.64 ± 4.2 mV 
and for pHint 8.5 107 ± 5.8 mV. For statistical testing, a Scheffe’s test was performed for 
multiple comparisons between the three groups, revealing however no significant 
differences. 
 
 
 
Figure 3.7: The sensing of Dr-VSP was not affected by the different pHint.  A: Representative 
recording of sensing (gating) currents of Dr-VSP. The voltage sensor moves outwards in 
response to increasing membrane potential. B: No significant shift in the Q-V curve between 
the different intracellular pH values. e=14 for pHint 6.5, e=14 for pHint 7.5, e=9 for pHint 8.5. 
 
3.1.3.3 pH does not affect the kinetics of PI(4,5)P2 resynthesis 
PI(4,5)P2 levels depend on the simultaneous activity of PI(4)P 5-kinases and VSP (Fig. 
3.8A). Here we considered the possibility that the increased PI(4,5)P2 depletion 
observed under acidic conditions results from impairment of the kinase activity. To 
test this hypothesis we estimated the rate of PI(4,5)P2 resynthesis from time course 
TIRF experiments as demonstrated in figure 3.8A, which represents the kinase activity. 
Specifically we calculated the time constant τ by fitting the data to the exponential 
function. The rates of PI(4,5)P2 resynthesis were not significantly different between 
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different intracellular pH values for all three tested VSPs (Fig. 3.8B), indicating that the 
kinetics of the PI(4,5)P2 resynthesis remain stable. Hence, this finding further supports 
the hypothesis that the observed differences result from changes in VSP activity. 
 
 
Figure 3.8: The kinetics of PI(4,5)P2 resynthesis are not affected by the pHint.  A: Decreased 
PI(4,5)P2 levels can occur either because of increased VSP activity or because of decreased 
PI(4)P 5-kinase activity. By estimating the rate of PI(4,5)P2 resynthesis it is possible to evaluate 
the kinetics of the kinase activity. Red dotted line represents the fitting of the curve to the 
exponential function in order to estimate the τ value. B: PI(4,5)P2 recovery rates for Dr-VSPs, 
Ci-VSP and Xl-VSP1 under different intracellular pH conditions. No statistically significant 
differences between pHint 6.4 and pHint 8.3 were observed by perfoming a Student's T-test. 
3.1.3.4 The pH sensitivity is not mediated by the pH buffer  
In a study on the regulation of connexin channels by pH (Bevans and Harris, 1999) it 
was shown that the observed pH sensitivity was not due to the protonation of the 
channel but resulted from protonation state of the pH buffer used. Specifically, 
protonated aminosulfonate compounds, commonly used as pH buffers, directly 
inhibited connexin channel activity in a pKa related manner. 
Similar to the connexin example, we considered that the protonated form of HEPES, 
(pKa value of 7.5 at 25°C), could potentially affect VSP activity and thereby account for 
the pH sensitivity of PI(4,5)P2 depletion. Moreover, we wanted to test if the pH 
buffering of HEPES at extreme pH values was efficient, since this buffer is considered 
useful at pH range 6.8-8.2. We therefore compared HEPES with TAPS, a buffer with pKa 
value of 8.5 at 25°C and useful pH range 7.7-9.1 (Fig. 3.9A). Because of the different 
pKa values of these two buffers the protonation of HEPES would be substantially lower 
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than that of TAPS at pH 8.3. TIRF experiments in cells expressing Dr-VSP and PLCδ1-PH-
GFP were performed at pHint 8.3 using HEPES or TAPS (Fig. 3.9B). The responses 
observed with the two pH buffers were indistinguishable, suggesting that the 
differences in the PI(4,5)P2 depletion could not be explained by an interaction of the 
buffer with the Dr-VSP. In addition, the finding suggested that pH buffering of HEPES 
was sufficient at pH 8.3. 
 
Figure 3.9: pH sensitivity of PI(4,5)P2 depletion is independent of the buffer.  A: Chemical 
structures of HEPES and TAPS. They share a common structural motif of the protonatable 
amine but present different pKa values and pH ranges. B: No difference in the PI(4,5)P2 
depletion between HEPES (e=5) and TAPS (e=7) at pHint 8.3.  
3.1.3.5 Testing the involvement of single histidines in the pH sensitivity  
As reviewed in (Srivastava et al., 2007) several proteins have been found to be 
regulated by intracellular pH changes by means of alternation of their conformation or 
by changes of their interactions with other molecules. A key role in these processes is 
played by the protonation state of titratable residues and particularly histidine that has 
a pKa value of 6.1 (Fig. 3.10A). At acidic pH, protons bind to histidines changing the 
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electrostatic forces and consequently the protein structure (Lukin and Ho, 2004) or 
increasing the affinity of the protein to its ligands (Miura et al., 1999). 
Similarly, it is possible that protons directly interact with VSPs increasing their catalytic 
activity. To test this hypothesis, we investigated the possible existence of pH-sensing 
histidines in VSPs, which could account for the observed pH dependence of PI(4,5)P2 
depletion. Single site mutations were performed at the positions H239, H271, H301 
and H490 of the phosphatase domain of Dr-VSP. These histidines were chosen since 
they are conserved among the three VSPs that demonstrated pH sensitivity (Fig. 
3.10B). Histidines were substituted by the positively charged arginine, mimicking the 
protonated state of histidine. Since protonation state of arginine (pKa=12) is predicted 
to remain constant at the pH range used in these experiments, it was anticipated that 
substitution of putative pH-sensing histidines with arginines would abrogate the pH 
sensitivity of Dr-VSP. 
 
 
 
Figure 3.10: Mutagenesis of histidines does not abolish the pH sensitivity of Dr-VSP. A: Under 
acidic conditions histidine exists in its protonated form. B: Dr-VSP contains eleven histidines 
within its cytoplasmic region. Four of these histidines are conserved among the Dr-VSP, Ci-VSP 
and Xl-VSP (all three VSPs present similar pH dependent activity Fig.3.5). C: Substitution H239R 
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and H271R resulted in proteins demonstrating no activity (n.a.) while the H301R and H490R 
mutants retained the pH sensitivity, seen here as increased PI(4,5)P2 depletion. D: Substitution 
of H239A and H301A resulted in a catalytically inactive protein while substitutions H271A and 
H490A still demonstrated increased PI(4,5)P2 depletion under acidic contiditons. A minimum of 
4 cells per experiment was obtained. 
 
We performed TIRF experiments in cells coexpressing Dr-VSP mutants with PLCδ1-PH-
GFP and compared the phosphatase activity between pHint 6.4 and 8.3. For the 
mutants H239R and H490R the pH sensitivity persisted, indicating no involvement of 
these histidines in the pH sensing (Fig. 3.10C). The remaining two mutants, H271R and 
H301R, resulted in a catalytically inactive protein, providing therefore no information 
about the involvement of these histidines in the pH dependence. We considered that 
the larger size of the arginine could account for the loss of protein function by 
interfering with the original protein conformation. Therefore to further examine these 
positions, we mutated histidine to the small and neutral amino acid alanine, to achieve 
minimal disturbance of the protein. This time, mutation in the position H301 resulted 
in an active but pH sensitive response while the H271A mutant remained inactive (Fig. 
3.10D). In summary, identification of a single histidine accounting for the observed pH 
dependence was not possible. 
3.1.3.6 Oxidation inhibits the phosphatase activity of Ci-VSP 
Reactive oxygen species (ROS) at low and controlled levels can play a role in various 
signaling pathways, including cell survival and growth pathways, by affecting the 
activity of target proteins, such as transcription factors, growth factor receptors and 
phosphatases (Holmström and Finkel, 2014). ROS are also known to regulate sperm 
capacitation via the regulation of tyrosine phosphorylation (de Lamirande and 
O’Flaherty, 2008). The most frequent targets of ROS are cysteine residues that under 
oxidizing conditions form disulfide bonds with proximal intramolecular cysteines, 
changing thus the conformation of the protein (Fig. 3.11.A).  
Ci-VSP and PTEN have also been suggested to be regulated by oxidation (Lee et al., 
2002; Matsuda et al., 2011). In the work of Matsuda et al., the crystal structure of Ci-
VSP's cytoplasmic region revealed that the protein can exist in two forms: the first 
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form presented a disulfide bond between C363 and C310, while the second form 
lacked such bond. These cysteines are conserved in PTEN where they interact under 
oxidative conditions, inhibiting phosphatase activity (Lee et al., 2002). However, so far 
only in vitro assays were used to assess the effect of oxidation on Ci-VSP and PTEN 
phosphatase activity. Given the possible involvement of Ci-VSP in cell growth and 
sperm physiology, here we systematically studied the effect of different redox agents 
on Ci-VSP in living cells.  
CHO cells expressing Ci-VSP and the PI(4,5)P2 sensor PLCδ1-PH-GFP were treated with 
the oxidizing agents hydrogen peroxide (H202) or glutathione disulfide (GSSG), or with 
the reducing agent dithiothreitol (DTT). In a representative recording shown in figure 
3.11B, a cell initially responding to a +80 mV pulse, demonstrated no phosphatase 
activity after application of 5 mM H2O2 for 5 minutes, indicating inhibition of Ci-VSP, 
while lower concentrations of peroxide only partially inhibited the protein (Fig. 3.11C). 
Application of peroxide did not influence the sensing currents of Ci-VSP suggesting that 
only the phosphatase domain of the protein is affected by oxidation (Fig.3.11D). The 
mild oxidant GSSG and the reducing agent DTT had no effect on the phosphatase 
activity (Fig. 3.11F). Based on the crystal structure of Ci-VSP the disulfide bond 
between the C310 and C363 may account for oxidative inhibition (Matsuda et al., 
2011)(Fig. 3.11E). To examine the involvement of the C310 in the inhibition we 
mutated this amino acid to serine, which is similar to cysteine but lacks the sulfur and 
is therefore unable to form disulfide bridges. Indeed the C310S mutant was less 
sensitive to inhibition by H202 compared to the WT Ci-VSP (Fig. 3.11F).  
In conclusion, VSPs can be regulated, in addition to voltage, by intracellular pH or 
oxidation. While structural and functional data strongly suggest disulfide bridge 
formation between C310 and C363 as the mechanism for inhibition via oxidation, it 
remains unknown whether pH changes can directly affect the phosphatase activity of 
VSPs.  
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Figure 3.11: The effect of oxidation on the phosphatase activity of Ci-VSP.  A: Under oxidizing 
conditions cysteine residues form disulfide bonds altering thus the conformation of the 
protein. B: Incubation with 5 mM H202 for 5 minutes in cells coexpressing Ci-VSP and PLCδ1-PH-
GFP completely inhibited the phosphatase activity of the protein. C: H202 concentration curve 
deriving from experiments as in panel B. D: The gating of Ci-VSP is not affected by application 
of 5 mM H202 for 5 minutes. E: Schematic of Ci-VSP showing the position of the cysteines that 
are involved in the inhibition by oxidation. F: Graphs comparing the effect of redox agents on 
WT Ci-VSP as well as the effect of 5 mM H202 on Ci-VSP C310S mutant (white bar). 
3.2 Development of an experimentally simple method for 
manipulation of cellular PI concentrations and for analysis 
of PTEN 
All experiments described above were performed using the patch-clamp technique to 
control VSPs activity by membrane potential. This laborious technique requires 
electrophysiological instrumentation and time consuming, single cell measurements, 
which clearly limit the accessibility and popularity of VSPs as tools for manipulating PI 
levels in living cells. In the second part of this thesis we aimed at developing an 
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approach where membrane depolarization is achieved by activation of cation 
channels, to allow for a technically simple way to control VSPs activity in populations 
of living cells. 
3.2.1 Activation of Ci-VSP in intact cells by membrane depolarization via 
cation channels…… 
To activate VSPs without electrophysiology we developed the experimental strategy 
depicted in figure 3.12A, where overexpressed cation channels are used to depolarize 
the cell membrane, thereby activating the VSP. To monitor VSPs activity we used the 
same basic detection strategy as before, which involves fluorescence-tagged 
biosensors specific for the VSP’s substrates (Várnai and Balla, 2006). 
We started by exploring cation channel based strategies to activate the prototypical Ci-
VSP. First, the K+ channels TASK-3 or KCNQ4 (Kv7.4) were used to depolarize the cells. 
These channels have substantial open probability under basal conditions, since TASK-3 
is a constitutively open “leak” channel (Enyedi and Czirják, 2010), whereas KCNQ4 is a 
voltage gated channel open at potentials above -50mV, when expressed in CHO cells 
(Chambard and Ashmore, 2005). Given that both channels provide a substantial K+ 
conductance, cell depolarization can be simply achieved by increasing the extracellular 
K+ concentration. 
Indeed, we observed PI(4,5)P2 depletion as reported by translocation of the PI(4,5)P2 
biosensor tubbyC-GFP (Santagata et al., 2001) when 150 mM K+ was applied to cells co-
expressing Ci-VSP and either KCNQ4 or TASK-3 (Fig. 3.12B and C). Strong and rapid 
activation of Ci-VSP was achieved with either channel. Slightly more cells cotransfected 
with KNCQ4 (92%) than cells cotransfected with TASK-3 (80%) responded to 
application of K+. Therefore KCNQ4 was used for further experiments. When co-
expression of channels was omitted, only 50% of the cells responded to application of 
K+ and changes in PI(4,5)P2 concentration were weak (Fig. 3.12C), indicating that, at 
least in CHO cells, endogenous K+ channels were not sufficient to strongly drive Ci-VSP 
activity. The translocation of tubbyC-GFP was completely absent when catalytically 
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dead Ci-VSP C363S was used (Fig. 3.12C), confirming that sensor translocation resulted 
from Ci-VSP mediated PI(4,5)P2 depletion. 
VSPs can be used to deplete PIs in a gradual fashion by imposing graded membrane 
depolarization (Halaszovich et al., 2009). Membrane potential has a roughly 
logarithmic dependence on extracellular K+ when membrane properties are dominated 
by the K+ conductance, suggesting that membrane potential and consequently Ci-VSP 
activity can be gradually increased by elevating extracellular [K+]. In fact, when various 
K+ concentrations were washed in, Ci-VSP activity, measured as the degree of 
translocation of the biosensor, was also graded (Fig. 3.12D). Maximum activity 
occurred at 150 mM K+, which was the maximum concentration we could achieve 
while keeping physiological osmolarity.  
As an alternative approach to achieve membrane depolarization we utilized the 
capsaicin-activated TRPV1 channel (Fig. 3.12E), a non-selective cation channel that 
depolarizes the membrane when active (Caterina et al., 1997). Because TRPV1 is also 
Ca2+ permeable and Ca2+ influx could potentially activate PLC (Rebecchi and Pentyala, 
2000) to cause PI(4,5)P2 cleavage, we used Ca
2+-free extracellular solutions in these 
experiments. Application of capsaicin to HEK cells coexpressing TRPV1, Ci-VSP and 
tubbyC-GFP resulted in robust PI(4,5)P2 depletion, whereas no effect was observed in 
the absence of TRPV1 or Ci-VSP (Fig. 3.12E). 100 nM of capsaicin was sufficient to 
induce the full response, as demonstrated by the capsaicin concentration-response 
curve (Fig. 3.12F). 
Over the last years, light-activated prokaryotic ion channels have been established as 
optogenetic tools for manipulation of the membrane potential (Lin, 2011). Among 
these channels, Channelrhodopsin-2 (ChR2), has been studied extensively and used 
widely to depolarize cells. ChR2 is a non-selective cation channel activated by visible 
light with a response spectral peak at around 450 nm (Nagel et al., 2003; Lin et al., 
2009). Since activation by light may enable enhanced spatiotemporal control and 
facilitate experimentation, we also attempted to use ChR2 to activate VSPs. 
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Figure 3.12: Activation of Ci-VSP by membrane depolarization through overexpressed cation 
channels. A: Scheme representing the general strategy used to activate Ci-VSP. Cells coexpress 
Ci-VSP, a PI biosensor and a cation channel. Cation influx into the cell results in membrane 
depolarization, activation of Ci-VSP, depletion of PI(4,5)P2 and lastly translocation of the sensor 
to the cytoplasm. BS, biosensor; PD, phosphatase domain. B: Confocal images of HEK cells 
coexpressing Ci-VSP, KCNQ4 and tubbyC-GFP acquired before, during and after application of 
150 mM K+. Fluorescence signal was recorded from cytoplasmic regions. Scale bar 20 µm. C: 
Time series of relative increase of cytoplasmic fluorescence calculated from CHO cells 
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expressing Ci-VSP, tubbyC-GFP and the K+ permeable channels TASK-3 (n=48, e=16), KCNQ4 
(n=82, e=16) or no channel (n=28, e=9). The catalytically dead mutant Ci-VSP C363S (n=23, 
e=8) was used as negative control. TubbyC translocates to the cytoplasm upon 150mM K+ 
application for 1 minute. D: K+ concentration-response curve from HEK cells coexpressing Ci-
VSP, tubbyC-GFP, and KCNQ4 (n=15, e=6). E: Application of 100 nM capsaicin in HEK cells 
coexpressing TRPV1 channel, Ci-VSP and tubbyC-GFP resulted in Ci-VSP activation and tubbyC 
translocation (n=25, e=8). No effect was observed in the absence of Ci-VSP (n=19, e=7) or 
TRPV1 (n=16, e=6). F: Capsaicin concentration-response curve (EC50 = 29 ± 3nM; at least 10 
cells per concentration). G: ChR2-mediated membrane depolarization. Representative current 
clamp recording from a CHO cell expressing ChR2, without current injection (Ihold=0pA). 
Membrane depolarization increased under low pH extracellular conditions. H: Activation of 
ChR2 with violet (426 – 446 nm) or blue (450 – 490 nm) light exposure for 10 seconds in HEK 
cells coexpressing tubbyC-RFP and Ci-VSP. tubbyC translocation was observed only at 
extracellular pH 6.5 (n=12, e=4), but not at pH 7.5 (n=11, e=4) or with the catalytically dead Ci-
VSP C363S mutant (n=23, e=4). I: Exposure time-response curve showing that 10 seconds of 
exposure with blue light resulted in maximal tubbyC translocation.  
 
We first explored conditions for sufficient depolarization by ChR2. Extracellular 
acidification (pH 6.5) turned out to strongly increase the depolarization of cells 
expressing ChR2 when stimulated with blue light (Fig. 3.12G), most likely due to the 
high H+ permeability of ChR2 (Nagel et al., 2003). This finding suggested low 
extracellular pH as the optimal condition to activate Ci-VSP via ChR2. Indeed, Ci-VSP 
was successfully activated only when extracellular solution of pH 6.5 was used but not 
at the standard extracellular pH 7.4 (Fig. 3.12H). As in the case of TRPV1, we used Ca2+-
free solution to prevent activation of PLC by Ca2+ influx. 10 seconds of blue or violet 
light exposure were sufficient for maximal stimulation of Ci-VSP, measured via 
translocation of tubbyC-RFP to the cytoplasm (Fig. 3.12I). An RFP-tagged sensor was 
used in these experiments, because GFP excitation interferes with ChR2 activation. 
To compare the performance of the above methods of Ci-VSP activation, we evaluated 
the maximal response to each stimulus as well as the time required for PI(4,5)P2 
depletion (i.e. sensor translocation) and the time required for PI(4,5)P2 recovery after 
cessation of the stimulus. Activation of all three channel types resulted in robust 
PI(4,5)P2 depletion. Specifically, Ci-VSP activation induced by TRPV1 and ChR2 was 
slightly, but not significantly, stronger (sensor translocation 1.63 ± 0.09 and 1.65 ± 
0.064 fold, respectively), compared to the KCNQ4-mediated response (1.51 ± 0.04 fold 
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increase; Fig. 3.13A). The fastest response (Fig. 3.13B) was observed using ChR2 (t1/2 = 
4.35 ± 0.42s, followed by KCNQ4 (t1/2 = 18.2 ± 1.75s) and TRPV1 (t1/2 = 25.02 ± 3.73s). 
For the recovery after stimulation, t1/2 was 12.37 ± 1.24s for ChR2, 19.92 ± 2.73s for 
KCNQ4 and 27.89± 3.05s for TRPV1 (Fig. 3.13C). 
 
Figure 3.13: Comparison of the three depolarization methods in HEK cells cotransfected with 
Ci-VSP, tubbyC and one of the different channels.  A: Bars representing the maximal response 
observed by overexpression of KCNQ4, TRPV1 and ChR2. For KCNQ4 we used the tubbyC 
translocation value from experiments as in graph Fig. 3.12C, for TRPV1 from graph Fig. 3.12E 
and for ChR2 the maximal value from the blue light activation in graph Fig. 3.12H. B: Bars 
representing t1/2 of initiation, meaning the time required to reach 50% of the maximal 
response, for the three channels, calculated from data summarized in Fig. 3.12C, Fig.3.12E, and 
Fig.3.12I respectively. C: Bars showing t1/2 of recovery, the time required for 50% recovery to 
baseline. Numbers in columns represent the number of cells. 
3.2.2 Monitoring Ci-VSP activity without imaging 
The above method for monitoring PI depletion is based on the translocation of PI 
sensors between cytosol and plasma membrane. Detection of translocation requires 
imaging-based experiments with subcellular resolution, usually involving confocal 
microscopy (Murata and Okamura, 2007) or advanced microscopy techniques such as 
TIRF microscopy (Halaszovich et al., 2009). Such approaches may not be optimal in 
many experimental settings including high-throughput assays, because experiments 
and analysis are based on single-cell data and thus are time-consuming, may be 
difficult to automatize, and involve costly and complex equipment (e.g., confocal 
microscope, laser, TIRF-lenses). One way to circumvent these disadvantages is to 
employ PI sensors based on Förster resonance energy transfer (FRET).  
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Previously, pleckstrin homology (PH) domains of phospholipase C δ1 (PLCδ1-PH) fused 
to CFP and YFP have been used as FRET probes to detect PI(4,5)P2 concentration 
dynamics (Várnai and Balla, 1998; Falkenburger et al., 2010b; Hertel et al., 2011); 
dissociation of the domains into the cytosol increases their distance, thus reducing 
FRET between both fluorophores (Fig. 3.14A). As shown in figure 3.14B and C, 
activation of Ci-VSP with capsaicin in cells coexpressing TRPV1, PLCδ1-PH-CFP and 
PLCδ1-PH-YFP induced synchronous increase in CFP signal and a decrease in the FRET 
efficiency. Here, we used photodiodes to measure both CFP and YFP fluorescence 
emission, demonstrating that the FRET-based approach eliminates the need for 
microscopic spatial separation of membrane-bound and cytosolic fluorescence.  
 
Figure 3.14: FRET sensors to monitor Ci-VSP activation. A: Schematic representation of two 
different FRET sensors used to monitor Ci-VSP activity using photometry. PLCδ1-PH-CFP and 
PLCδ1-PH-YFP are located at the membrane before Ci-VSP activation and act as FRET donor and 
acceptor, respectively. FRET is disturbed when the sensors translocate to the cytoplasm after 
activation of Ci-VSP. Frubby is a construct that allows for intramolecular FRET and as shown in 
the schema it is held at the plasma membrane via a CaaX motif. B: Representative trace of 
fluorescence signal from a cell expressing Ci-VSP, TRPV1 channel, PLCδ1-PH-CFP and PLCδ1-PH-
YFP. Treatment with capsaicin results in an increase of CFP and a decrease of FRET signal. C: 
FRET ratio traces of the two FRET sensor systems. Both the PLCδ1-PH–CFP and PLCδ1-PH–YFP 
70 
 
system (e=15) and frubby (e=13) show a robust decrease of FRET ratio. No decrease in FRET is 
observed when the catalytically dead mutant Ci-VSP C363S (e=6) is used. 
 
We further sought to improve this approach, because consistency and reliability of this 
method may suffer from variable expression stoichiometry of both PH domains and 
from changes in fluorescence intensity resulting from sensor translocation. We 
therefore additionally used an intramolecular FRET sensor where CFP and YFP coexist 
in a single molecule. Such a sensor, based on PLCδ1-PH and anchored to the PM via a 
CAAX-box has been developed previously and termed Pippi-PI(4,5)P2 (Yoshizaki et al., 
2007). However, dual sensitivity of the PLCδ1-PH sensor domain to both PI(4,5)P2 and 
IP3 may be a problem under some experimental conditions (Várnai and Balla, 2006; 
Szentpetery et al., 2009). In contrast, tubbyC combines insensitivity to IP3 release 
(Quinn et al., 2008) with suitable sensitivity to changes in PI(4,5)P2 levels as shown 
previously (Halaszovich et al., 2009) and in figure 3.12. Thus, our laboratory colleague 
Dr. Daniela Schreiber designed and constructed the “frubby” sensor (Fig. 3.14A). In 
frubby the PLCδ1-PH domain of the original Pippi-PI(4,5)P2 sensor (Yoshizaki et al., 
2007) was replaced by tubbyC as the PI(4,5)P2-binding domain. We went on to 
combine detection of PI(4,5)P2 changes using frubby with activation of Ci-VSP by 
TRPV1. As shown in figure 3.14C, application of capsaicin to cells coexpressing frubby, 
Ci-VSP and TRPV1 induced a strong FRET ratio change. Notably, signal amplitude was 
similar, but signal variability was smaller and reversibility was more complete 
compared to the bi-molecular FRET sensor (Fig. 3.14C).  
In conclusion, the combination of ligand-controlled activation of Ci-VSP together with 
FRET detection using the frubby sensor allowed for the temporally precise depletion of 
PI(4,5)P2 in intact cells and concomitant monitoring of PI(4,5)P2 changes without the 
need for single-cell imaging.  
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3.2.3 PTENCiV chimera for functional analysis of the tumor suppressor 
PTEN 
Similarly to the approach we used for Ci-VSP, we attempted to activate PTENCiV 
without electrophysiological methods and compare the phosphatase activity of 
different PTEN mutants. 
First we aimed to optimize the method by selecting the appropriate channel and 
sensor that would provide the most robust responses. We selected TRPV1 for 
activation of PTENCiV for three reasons. First, it presented a more robust response 
compared to the KCNQ4 as shown in figure 3.15A and 3.15B. Second, application of 
high extracellular K+ concentrations interfered with some GFP-tagged biosensors, 
leading to a decrease in the fluorescent signal (Fig. 3.15B). This decrease does not 
represent translocation of the sensors, as fluorescence decrease was even observed 
when free GFP was cotransfected, instead of a sensor (Fig. 3.15C). As shown in figure 
3.15D, the PI(4,5)P2 sensor tubbyC-GFP showed stronger membrane association 
compared to PI(3,4,5)P3 sensors Akt-PH-GFP, Btk-PH-GFP, and GRP1-PH-GFP. Since we 
recorded the fluorescence signal from the interior of the cell, it is possible that the 
fluorescence decrease observed in panels B and C would be more pronounced with 
those domains that show higher cytosolic fluorescence under basal conditions. Vice-
versa, in previous experiments using tubbyC (Fig. 3.12C), a sensor that is strongly 
localized at the membrane, this fluorescence decrease was not observed. The third 
reason to select TRPV1 for these experiments was that we could not use ChR2 because 
activation of ChR2 with blue light is incompatible with GFP-tagged sensors for 
PI(3,4,5)P3. 
Since PTEN is a PI(3,4)P2/PI(3,4,5)P3 3-phosphatase, we also tested various sensor 
domains that specifically bind to these 3-phosphorylated PIs for their suitability to 
quantitatively assess activity of PTENCiV. Akt-PH-GFP and Btk-PH-GFP showed larger 
responses than GRP1-PH-GFP, as shown in figure 3.15A. Because response kinetics 
were faster for Akt-PH than for Btk-PH we chose Akt-PH as the most suitable sensor for 
subsequent experiments. 
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Figure 3.15: Selection of a suitable channel and sensor for studying PTENCiV.  A: Fluorescence 
traces resulting from TRPV1-mediated membrane depolarization. Cells expressing PTENCiV and 
TRPV1 channel were used to compare the different PI(3,4,5)P3 sensors Btk-PH-GFP (n=36, 
e=26), Akt-PH-GFP (n=31, e=16) and GRP1-PH-GFP (n=19, e=14). Akt-PH and Btk-PH presented 
the biggest responses. The green trace represents cells coexpressing the catalytically dead 
PTENCiV C124S, TRPV1 and Akt-PH-GFP. No effect was observed with the PTENCiV C124S mutant 
(n=14, e=7). B: Fluorescence traces resulting from KCNQ4-mediated membrane depolarization. 
Cells cotransfected with KCNQ4, PTENCiV and Akt-PH (n=34, e=12) or Btk-PH (n=15, e=12) 
present an increase of the fluorescence signal upon application of 150 mM K+. In contrast, 
application of K+ caused a decrease in the signal in control experiments with cells 
cotransfected with KCNQ4, PTENCiV C124S, Akt-PH (n=15, e=15), or in cells cotransfected with 
KCNQ4, PTENCiV and GRP1-PH-GFP, a PI(3,4,5)P3 sensor with low membrane affinity (n=14, 
e=8). C: Control experiment where free GFP was coexpressed with PTENCiV and KCNQ4. The 
cytoplasmic fluorescence signal also decreased upon K+ application. This implies that the 
decreases seen in panel B is most likely not due to an actual sensor translocation (n=22, e=11). 
D: Confocal images of HEK cells expressing different PI sensors. The PI(4,5)P2 sensor tubbyC-
GFP is strongly located to the membrane compared to PI(3,4,5)P3 sensors Akt-PH-GFP, Btk-PH-
GFP, and GRP1-PH-GFP. Scale bar 15µm. 
 
Having optimized the method in terms of channel and PI sensor, we then assessed its 
usefulness by examining the effect of mutations on the catalytic activity of PTEN. To 
this end, we focused on Lysine 125, located in the catalytic pocket of the protein (Fig. 
3.16A). PTEN mutations at this position are frequently found in cancer, according to 
COSMIC. 
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In addition to oncogenic K125R and K125N, we also analyzed K125L because all three 
PTEN mutants were previously examined with a yeast survival model (Rodríguez-
Escudero et al., 2011), thus allowing for direct comparison of methods. When 
challenged with capsaicin-triggered depolarization, all three mutants showed impaired 
phosphatase activity compared to “wildtype”, PTENCiV (Fig. 3.16B). K125R and K125L 
presented significantly reduced enzymatic activity, yielding maximum sensor 
translocation of 61.17 ± 5.48 % and 40.43 ± 5.11 %, respectively, relative to “wildtype” 
PTENCiV activity, while the K125N mutation resulted in a complete loss of enzymatic 
function (Fig. 3.16C).  
This approach expands and simplifies the study of PTEN mutations as presented in the 
section 3.1.2, where activation and thereby study of PTENCiV required patch clamping 
experiments. 
 
Figure 3.16: Analyzing PTEN mutations using PTENCiV and TRPV1 mediated membrane 
depolarization.  A: Schematic representation of PTENCiV. Point mutations were introduced at 
K125 located in the P-loop of the catalytic domain. Asterisks mark oncogenic mutations as 
reported at COSMIC database (http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/). 
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B: Time series traces of Akt-PH-GFP translocation upon activation with capsaicin in cells 
coexpressing TRPV1 channel and WT or mutated PTENCiV. C: Mean of Akt-PH-GFP translocation 
calculated for the last 30 seconds of capsaicin application, normalized to the average response 
measured with WT PTENCiV. Numbers in columns represent the number of cells. Statistically 
significant difference between WT and mutants is marked with *. 
 
3.2.4 PTENCiV can be exploited to test PTEN inhibitors 
Bisperoxovanadium (bpV) compounds are specific PTEN inhibitors and have been 
widely used to assess the role of PTEN in cellular processes (Schmid et al., 2004). They 
have been characterized using in vitro phosphatase assays and Western blot analyses 
of the phosphorylation of AKT, a downstream target of the PTEN pathway. We 
considered these compounds as a useful example for exploring the potency of the 
PTENCiV/live-cell approach in analyzing the effect of PTEN modulators on intact cells. 
We examined the effects of two compounds, bpV(HOpic) where bpV is attached to a 
polar functional group and bpV(phen) where bpV is attached to a neutral functional 
group. 
TRPV1 was used to activate PTENCiV as described above. Here, we measured 
membrane association of the PTEN activity sensor Akt-PH-GFP by TIRF microscopy. 
TIRF microscopy provides stable imaging particularly in experiments where longer 
incubations are required.  
First, cells were incubated with either bpV compound overnight and throughout the 
experiment. As shown in figure 3.17A, both compounds inhibited PTEN activity in a 
dose-dependent manner. Nearly complete inhibition was observed with 10 µM of 
bpV(phen) or bpV(HOpic). Inhibition was partially reversible when cells that were 
incubated overnight with 10 µM of bpV(phen) were washed and incubated with 5mM 
of the reducing agent DTT for 3 hours. 
To investigate the time course of the inhibition, which is less easily addressed by 
conventional biochemical methods, we monitored the same cells before and after 
application of inhibitors. Cells responsive to a first stimulation by capsaicin were 
incubated for 30 minutes with 200 µM bpV(phen). These cells did not respond to a 
second application of capsaicin indicating the inhibition of PTENCiV (Fig. 3.17B). 
Similarly, 30 minutes application of 200 µM of bpV(HOpic) greatly decreased the 
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phosphatase activity (Fig. 3.17C). Control experiments were performed where no 
inhibitor was applied between subsequent capsaicin treatments (Fig. 3.17D). In that 
case, the second response -although decreased- remained pronounced. This decreased 
response might be explained by incomplete recovery of PI(3,4,5)P3 levels.  
 
Figure 3.17: PTENCiV is inhibited by bisperoxovanadate compounds.  A: Bars representing the 
effect of overnight incubation of bisperoxovanadate compounds on PTENCiV activity. 
Fluorescence intensity was acquired with TIRF microscopy from HEK cells expressing PTENCiV, 
TRPV1 channel and Akt-PH-GFP. Decrease in the fluorescence signal recorded from the 
membrane is observed upon capsaicin application. Cells were treated with different 
concentrations of the PTEN inhibitors bpV(phen) or bpV(Hopic). Cells that after an overnight 
incubation with 10 µM bpV(phen) were washed out and incubated for 3 hours with 5 mM of 
the reducing agent DTT showed a partial recovery of phosphatase activity. B-D: Graphs 
demonstrating the effect of the inhibitors in real time. B: HEK cells that had initially responded 
to a 100 nM capsaicin activation were incubated for 30 minutes with 200 µM of the inhibitors 
bpV(phen). After the 30 minutes incubation they presented no response to a second capsaicin 
application (n=11, e=4). C: Application of the inhibitor bpV(Hopic) also impairs PTENCiV activity 
(n=10, e=4). D: Graph showing a control experiment where no inhibitor was applied between 
the two capsaicin applications (n=9, e=3). Statistically significant difference between control 
and treated samples is marked with *, while the # sign indicates significant difference between 
the 10 µM bpV(phen) and the DTT treated samples. Numbers in columns represent the 
number of cells. 
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The much lower efficacy of bpV in acute application when compared to overnight 
incubation may indicate that permeation into the cell membrane is slow. To examine 
the inhibitors without the above limitation, we performed patch clamp experiments 
where bpV compounds were applied intracellularly through the patch pipette (Fig. 
3.18A). PTENCiV was activated with a voltage jump from -60 mV to +80 mV for 30 
seconds. Complete inhibition occurred at 10 µM of bpV(phen) and bpV(Hopic) (Fig. 
3.18C,D), similarly to our previous observations with overnight incubations. Patch 
clamp experiments also allowed us to record sensing currents of PTENCiV. We saw no 
change in the sensing currents, which confirms that the inhibitor acts specifically on 
the phosphatase domain and does not impair the VSD function (Fig. 3.18B). In 
conclusion, when the inhibitor was applied intracellularly, the inhibitory 
concentrations were similar to the concentrations required with overnight incubation, 
indicating that the peroxovanadate compounds permeate slowly through the cell 
membrane. 
 
Figure 3.18: bpV(phen) and bpV(HOpic) abolish PTENCiV activity at micromolar concentrations 
when applied intracellularly. A: Representative recordings from patch clamped CHO cells 
expressing PTENCiV and Akt-PH-GFP. 10 µM of inhibitor in the pipette completely abolish 
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PTENCiV phosphatase activity when PTENCiV was activated with a voltage jump from -60 mV to 
+80 mV for 30 seconds. B: Sensing current recorded at +120mV from a holding potential of -70 
mV from a cell where 10 µM of bpV(phen) was applied though the patching pipette. C and D: 
Dose response curve for bpV(phen) and bpV(Hopic) derived from experiments as in panel A. 
3.2.5 PTENCiV activation allows for rapid control of PI3K downstream 
pathways…… 
The major role of PTEN is to antagonize the phosphatidylinositol 3-kinase (PI3K) 
signaling pathway. This pathway is controlled by the serine-threonine protein kinase 
AKT which is recruited and activated by plasma membrane PI(3,4,5)P3 and in turn 
regulates a plethora of downstream targets through a cascade of protein kinases 
(Brazil et al., 2004). A simplified schematic of the PI3K signaling pathway is shown in 
figures 1.5 and 3.19A. 
 
Figure 3.19: Activation of PTENCiV leads to rapid dephosphorylation of FOXO1.  A: PTENCiV 
activation decreases PI(3,4)P2/PI(3,4,5)P3 levels which results in AKT’s displacement from the 
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plasma membrane. This displacement prevents the phosphorylation and activation of AKT by 
PDK1. AKT is then unable to phosphorylate downstream targets like FOXO1. B: Schematic 
representation of the AKT activation reporter, AktAR. FOXO1 at the phosphorylated state 
dimerizes with the Forkhead associated (FHA) domain and results in approach of the 
fluorophores. Activation of PTENCiV should disrupt this interaction. C: FRET ratio traces of cells 
expressing TRPV1, PTENCiV and AktAR. Activation of PTENCiV with 100 nM of capsaicin for 10 
minutes results in a decrease of the FRET signal, indicating the rapid dephosphorylation of 
FOXO1 (n=11, e=4 for PTENCiV; n=9, e=3 for PTENCiV C124S). FRET experiments performed by V. 
Thallmair. 
 
We wondered if our method to rapidly change PTEN activity might have the potential 
to interrogate the dynamics of PI3K signaling. To assess the effect of PTENCiV on 
downstream targets of the AKT signaling pathway we utilized the AKT activity reporter, 
AktAR, described by (Gao and Zhang, 2008). AktAR is a membrane-anchored FRET 
sensor to monitor the kinase activity of AKT that is composed of part of the AKT-
recognition sequence of FOXO1 and a forkhead-associated domain (FHA1). AKT-
dependent phosphorylation of FOXO1 leads to dimerization of the two domains and an 
increase in the FRET signal, i.e. the FRET ratio directly correlates to the kinase activity 
of AKT (Fig. 3.19B). In cells coexpressing TRPV1, PTENCiV and AktAR, application of 
capsaicin for 10 minutes indeed led to a decrease of the FRET signal indicating 
decreased AKT activity. In contrast, no decrease was observed when catalytically-dead 
PTENCiV C124S was coexpressed (Fig. 3.19C). In conclusion ligand-induced activation of 
PTENCiV does not only allow to manipulate PI(3,4,5)P3 at the plasma membrane but 
also to control and analyze the downstream signaling cascade including 
phosphorylation of AKT substrates in intact living cells. 
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4 Discussion 
4.1 Functional characterization of VSPs 
4.1.1 Generation of chimera for targeting hVSP1 to the membrane 
Although our understanding about non-mammalian VSPs has substantially increased 
over the last decade, the function of the mammalian VSPs including their substrate 
specificity remained mostly unknown. The study of human VSPs has been proven 
particularly challenging because of specific characteristics of these proteins: in 
heterologous expression systems hVSP1 is shown to be catalytically active in vitro 
without being located at the plasma membrane, while hVSP2 (the isoform hVSP2-3) 
localizes at the membrane but demonstrates no phosphatase activity in vitro (Chen et 
al., 1999; Walker et al., 2001; Tapparel et al., 2003; Halaszovich et al., 2012). 
This localization of hVSP1 in intracellular membranes in our expression system had 
restricted us so far from further electrophysiological investigation of this protein. Of 
note, in native tissue hVSP1 is found in spermatocytes, brain and stomach but its 
subcellular localization is unclear (Walker et al., 2001). It seems possible that hVSPs 
localize and operate in these compartments but in this case they might be activated by 
other mechanisms, speculatively pH, since voltage regulation in Golgi and ER is 
unlikely. It remains therefore ambiguous whether the lack of plasma membrane 
localization is an artifact of the heterologous expression or it resembles the natural 
location of the protein. 
We sought for a way to target hVSP1 in the plasma membrane by maintaining its 
original structure as intact as possible. Exchange of the N-terminus or the entire 
voltage sensor of hVSP1 with the membrane targeted hVSP2-3 did not result in plasma 
membrane localization. Only replacement of the entire voltage sensor with the Ci-VSP 
resulted in plasma membrane localization and voltage activation. To further 
understand the mechanisms of membrane localization of VSPs, we truncated Ci-VSP, 
hVSP1 and hVSP2 right after the linker domain, generating therefore proteins that only 
consist of the voltage sensor domain. Interestingly, all truncated proteins presented 
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plasma membrane localization, with hVSP1-VSD being characterized by a clustered 
distribution in the membrane (data not shown). This finding indicates that all VSDs 
alone have the potential to reach the membrane but some putative ER or Golgi signal 
located within the phosphatase domain might restrain hVSP1 in these compartments. 
It is therefore possible that two opposing forces within hVSP1 decide the destination 
of the protein. This might explain why the hVSP1CiV chimera presents membrane 
localization and activation but considerably weaker than Ci-VSP. 
An interesting observation is that even with hVSPs that demonstrated membrane 
localization, such as hVSP2-3 and the truncated hVSP1, we detected no sensing 
currents. This raises the question why the voltage sensor of hVSPs, despite its high 
sequence similarity to non-mammalian VSPs, remains inactive. We performed a series 
of experiments to address this question without however succeeding so far. We sought 
for a residue in the hVSP1 voltage sensor that could potentially account for this loss of 
electrical activity. The strategy we followed was to exchange the charged residues (as 
they are shown to be crucial for the sensing) of the Dr-VSP's voltage sensor domain to 
the corresponding residues of hVSP2 and expect for a loss of the voltage sensor's 
activity. Nonetheless, all these mutated proteins retained their voltage sensitivity, 
suggesting that any other residue(s) could inhibit the voltage sensor activation. 
Therefore, further investigation is required to understand the cause of the loss of 
electrical activity in hVSPs.  
An alternative suggestion about the role of hVSPs has been made by Sutton et al. 
(Sutton et al., 2012). In that work chimeric proteins were created by swapping the S3-
S4 segments of the VSD of Dr-VSP with the corresponding segments of hVSP1 or 
hVSP2. These chimeras acted as voltage-sensitive proton channels, highlighting the 
possibility that mammalian VSPs evolved to have a surprisingly different function.  
However, we never detected any proton currents, even with constructs that strongly 
localize at the plasma membrane, such as hVSP2-3.  
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4.1.2 hVSP1 is a 5-phosphatase in living cells 
The present data of the enzymatic activity of hVSP1CiV chimera indicated that it acts as 
a 5-phosphatase which is inconsistent with previous in vitro phosphatase activity data 
that described the protein as a 3-phosphatase (Walker et al., 2001). Our data were 
acquired in living mammalian cells, and more closely represent the physiological 
environment of the native hVSP1 in comparison to the in vitro phosphatase data that 
were acquired using the isolated phosphatase domain and soluble substrates.  
Moreover, it seems unlikely that the attachment of a heterologous voltage sensor 
domain could change the phosphatase specificity from the 3 to the 5 position. There is 
no obvious mechanism by which the VSD could interfere with the substrate specificity 
of the phosphatase. The creation of PTENCiv chimera further supports this idea; 
attachment of VSD in the PTEN did not alter its specificity as a 3- phosphatase. 
Lastly, the P-loop of the catalytic center of hVSP1 containing a glycine in the HCX5R 
motive (Fig. 1.6B) is identical to Ci-VSP, Xl-VSP and Dr-VSP which are all 5-
phosphatases. On the other hand PTEN which acts as a 3-phosphatase comprises an 
alanine at the same position. Latest discoveries, part of those were mentioned in this 
thesis, revealed the importance of this position in the determination of the substrate 
specificity. This finding provides further support to the data presenting hVSP1 as a 5-
phosphatase.  
4.1.3 Novel oncogenic gain-of-function PTEN mutant 
Next we demonstrated the usefulness of the chimeric PTENCiV for the functional 
characterization of a patient specific somatic PTEN mutation. We showed that 
mutation of the alanine 126 to glycine located in the P-loop of catalytic center resulted 
in change of the substrate specificity of PTEN; A126G mutant acts as a 5-instead of 3- 
phosphatase of PI(3,4,5)P3. Such a gain of function mutation would lead to generation 
of PI(3,4)P2, a PI that is strongly involved in the regulation of cell migration and 
possibly tumor invasion (Oikawa and Takenawa, 2009). To show the relevance of 
A126G mutation in cell migration, our collaborators performed a scratch wound 
healing assay in a PTEN-null prostate cancer cell line heterologously expressing WT 
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PTEN, the catalytically dead mutant C124S or the A126G mutant. Indeed, they saw 
significantly increased cell migration at the A126G mutant compared to the 
catalytically dead mutant (Costa et al., 2015). 
The above findings demonstrate that not all PTEN mutations lead to the same deficient 
phenotype and that PTEN can have a more complex impact on the PI3K signaling than 
it was previously assumed. This highlights the importance of the identification of the 
PTEN mutation in a patient-specific manner, since treatment might vary based on the 
patients genotype. PTENCiV proved to be a powerful tool for the study of PTEN mutants 
providing information about the enzymatic activity of the protein. 
4.1.4 Does pH affect the catalytic activity of VSPs? 
To explore additional signals that regulate VSPs, we tested the effect of pH on the VSP 
activity. We performed patch clamping experiments with Dr-VSP and the PI(4,5)P2 
sensor PLCδ1-PH-GFP, using intracellular solution of different pH values (pHint). We saw 
that acidic intracellular pH leads to an increased PI(4,5)P2 depletion. 
However, the pH dependence of the depletion is not necessarily due to a direct effect 
of the pH on the catalytic activity of Ci-VSP. pH can affect several other parameters, 
such as the sensing mechanism of VSPs, the kinetics of kinase activity, the binding 
affinity of the PI sensor or PIs themselves. In this part we discuss the possible 
involvement of each of them in the pH dependence of PI(4,5)P2 depletion. 
To estimate the effect of pH on the gating of VSPs we measured the “On” sensing 
currents. We observed an 8.48 mV leftward shift of the V1/2 at pHint 6.5 compared to 
pHint 7.5 and a 0.35 mV rightward shift of the V1/2 at pHint 8.5 compared to pHint 7.5. 
These differences however were not statistically significant. It is important to be 
mentioned that these sensing currents are relatively small in amplitude (in the range of 
hundreds of pA) and it is possible that small shifts in the voltage dependence can be 
difficult to detect.  
Phosphoinositide levels in the living cell are rigidly regulated by the simultaneous 
action of phosphatases and kinases. Therefore the decrease in the PI(4,5)P2 levels 
observed might be attributed to the slowdown of the kinases' activity. We were able to 
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exclude that 5-kinases' activity was affected by the changes in the intracellular pH, by 
estimating the time constant of the PI(4,5)P2 resynthesis. These time constants were 
not significantly different among different intracellular pH, indicating that the kinetics 
of the PI(4,5)P2 resynthesis remain stable. 
An alternative explanation for the pH sensitivity observed is that acidic pH could 
decrease the binding affinity of our PI(4,5)P2 sensor PLCδ1-PH resulting therefore in a 
stronger dissociation from the plasma membrane. To our knowledge this has not been 
investigated previously. To exclude this possibility, we chose the pH insensible Kir2.1 
channel as a PI(4,5)P2 sensor to monitor Ci-VSP activity and observed that the pH 
sensitivity of the PI(4,5)P2 depletion remained. 
Alterations of intracellular pH would also change the protonation state and overall 
charge of the phosphoinositide itself. It was estimated that decrease of the pH value 
caused a decrease of the overall negative charge of the PIs (Kooijman et al., 2009). If 
we consider that electrostatic forces of the positively charged catalytic domain of Ci-
VSP with the negatively charged PI contribute to their binding, then it is possible that 
decrease of PI's charge could affect this interaction. It is however difficult to estimate if 
this charge change would favor or hamper the catalysis. In any case, if changes in the 
protonation of PIs is the reason for the pH dependence, no amino acid residues within 
the VSP will be identifiable as causative for the pH dependence. 
In conclusion, we showed for the first time that PI(4,5)P2 depletion by VSPs is sensitive 
to pH changes. Until now, the molecular mechanism by which acidification results in 
increased PI(4,5)P2 depletion remains unknown. Although a number of parameters 
have been excluded, it is an open question if the protonation of VSP itself is 
responsible for the effect. 
4.1.5 Interaction between C363 and C310 possibly underlies the 
inhibition of Ci-VSP by oxidation. 
Given the evidence that Ci-VSP and PTEN are regulated by oxidation (Matsuda et al., 
2011; Lee et al., 2002), here we systematically studied the effect of different redox 
agents on Ci-VSP in living cells. We found that only the strong oxidant H2O2 inhibits the 
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protein's phosphatase activity. Moreover we examined the involvement of the amino 
acid C310 in the process, which based on structural data is considered to form a 
disulfide bond with the C363 inhibiting thereby the catalytic activity of Ci-VSP. 
Substitution of C310 to serine resulted in a protein that was less sensitive to inhibition 
by H2O2. A potential explanation for this remaining degree of inhibition is that 
oxidation can affect proteins in several ways in addition to formation of disulfide 
bonds. For example, oxidation of cysteine can lead to thiyl radicals and mixed 
disulfides (e.g. with glutathione), while methionine residues can be oxidized to 
methionine sulfoxate (Shacter, 2000). These modifications could, theoretically, as well 
decrease the catalytic activity of Ci-VSP. 
To summarize our findings regarding the regulation of VSPs by pH and redox state, we 
saw that acidification acts as a positive regulator of VSPs, increasing the PI(4,5)P2 
depletion, whereas strong oxidation and alkalization have a negative effect on the 
activity of VSPs (Fig. 4.1). 
 
Figure 4.1: Summary of the regulation of VSPs by pH and oxidizing agents.  Oxidation by H202 
and alkalization negatively regulate the PI(4,5)P2 depletion, in contrast to intracellular 
acidification which results in increased PI(4,5)P2 depletion. 
4.2 Controlling VSPs and PTENCiV without electrophysiology 
As we have demonstrated so far, activation of VSPs in living cells requires the use of 
whole-cell patch clamping for the control of membrane potential. Since 
electrophysiological methods are not available to many laboratories, either because of 
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lack of equipment or electrophysiological expertise, we sought to find a simpler 
method for membrane depolarization. 
We developed a fast, simple, reversible and scalable method that can be used not only 
as a tool to control PI levels in living cells, but also to study the tumor suppressor PTEN. 
The approach is based on the well characterized Ci-VSP and the engineered 
phosphatase PTENCiV. Our data demonstrate that activation of overexpressed cation 
channels is an easy and powerful method to activate Ci-VSP or chimeric VSPs and 
thereby manipulate PI(4,5)P2 and PI(3,4,5)P3 concentrations in a temporally well-
controlled manner.  
4.2.1 Comparison of our method with previously described PI 
manipulation techniques 
Widely used methods for acutely altering PI concentrations are based on the 
recruitment of PI metabolizing enzymes to the membrane through a dimerization 
strategy, triggered either by rapamycin (Suh et al., 2006; Varnai et al., 2006) or via an 
optogenetic approach (Idevall-Hagren et al., 2012). Compared to these methods, the 
main advantage of the VSP-based approach is the reversibility of PI changes with times 
for 50 % recovery of 12 to 28 seconds. In contrast, the rapamycin system is virtually 
irreversible and with the optogenetic method half-maximal recovery of PI(4,5)P2 
requires several minutes (Idevall-Hagren et al., 2012). One additional disadvantage of 
the optogenetic approach is that its sensitivity to blue and green light places 
restrictions on which fluorophores can be used for imaging/monitoring purposes. On 
the other hand it allows for subcellular manipulation of PI concentrations, whereas VSP 
activation in our system always affects the entire plasma membrane of the cell. We 
further note that activation of VSPs by each of the tested ion channels allowed for a 
graded depletion of PI(4,5)P2. This high level of control over PI(4,5)P2 levels may be 
used to compare the apparent affinity of intracellular PI(4,5)P2 effectors in a semi-
quantitative manner, as demonstrated in this laboratory earlier (Halaszovich et al., 
2009). 
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4.2.2 Three different cation channels for induction of membrane 
depolarization 
Each of the three classes of channels explored here activated Ci-VSP with similar 
efficacy. Advantages and limitations of each channel type mostly relate to the 
technical aspects of channel activation. Depolarization through constitutively open K+ 
channels requires full exchange of bath solution to alter the K+ concentration; in some 
cases, high extracellular K+ concentrations interfered with GFP fluorescence (Fig. 
3.15C). Activation of ligand gated channels does not necessarily require complete bath 
exchange, since the ligand can be added to the bath solution, especially when small 
concentrations can be used; for the TRPV1 channel used here, an agonist 
concentration as low as 100 nM was sufficient for maximal effect. A disadvantage of 
using TRPV1 is the requirement for a Ca2+-free bath solution, although in many cases 
this will not be a severe restriction. Also, use of TRPV1 was the method showing the 
slowest kinetics, which is probably related to ligand permeation and 
binding/unbinding. Manipulations of the bath solution can be avoided altogether when 
the optogenetic approach using a light gated channel (ChR2) is used. Here, we 
achieved the fastest response times. Disadvantages of using ChR2 are that a low pH 
(6.5) and Ca2+-free bath solution had to be used and that the spectral characteristics of 
ChR2 preclude the use of certain wavelengths for excitation of fluorophores. Notably, 
we were not able to use GFP-tagged PI-sensors. 
4.2.3 Analysis of PTEN mutants and inhibitors 
Beyond manipulation of PI(4,5)P2 and PI(3,4)P2/PI(3,4,5)P3 levels, the availability of 
PTENCiV considerably extends the range of useful applications of the method presented 
here. The role of PTEN in pathological conditions like tumors of sporadic and germline 
origin and ASDs is well established (Hollander et al., 2011; Varga et al., 2009; Cantley 
and Neel, 1999). Biochemical in vitro techniques or a heterologous yeast reconstitution 
system have usually been used to investigate the effect of mutations on protein 
function or to study chemical PTEN inhibitors and activators. 
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The method we present should provide a useful complementation to the current 
spectrum of methods. We note several potential advantages of this approach. First, 
our method proved to be more sensitive than the published yeast-based method 
(Rodríguez-Escudero et al., 2011), in assessing the effect of PTEN mutations (see 
below). Second, in the living mammalian cell, PTEN acts on its substrates in the native 
membrane environment, which can differ substantially from the composition of 
vesicles used to present the substrates or even soluble substrate analogs used in in 
vitro assays. This might affect activity or substrate specificity inferred from such 
experiments, as demonstrated for hVSP1 which was first described as a 3-phosphatase 
based on in vitro data (Walker et al., 2001) but performed as a 5-phosphatase in living 
cells. Finally, the new method is applicable to a wide range of cell types, including cell 
lines derived from human tumors, once heterologous expression of the molecular 
components (VSP and cation channel) can be achieved in that cell line. 
To explore the potential of the method, we studied PTEN mutations, including known 
oncogenic mutations. For some of these PTEN mutations, results obtained with the 
PTENCiV approach were consistent with previously published findings from in vitro and 
yeast assays (Rodríguez-Escudero et al., 2011). Thus, PI(3,4,5)P3 phosphatase activity 
was strongly decreased for PTENCiV K125L and abrogated for PTENCiV K125N (Fig. 
3.16B,C). However, the yeast survival method previously did not detect any defect of 
the PTEN K125R (Rodríguez-Escudero et al., 2011), although the mutant is annotated 
as an oncogenic mutation. Our approach indeed detected a decrease of phosphatase 
activity by 40%. This finding might explain the tumorigenic effect of that mutation and 
also highlights the sensitivity of the VSP approach. As ASDs related mutations have 
been shown to decrease but not abrogate PTEN phosphatase activity (Rodríguez-
Escudero et al., 2011) this high sensitivity should render our method a well-suited tool 
for testing ASDs and tumor associated PTEN mutations. 
Similarly, the PTENCiV method enabled analysis of pharmacological manipulation of 
PTEN. In vitro and in vivo, bpV compounds inhibit PTEN at nanomolar concentrations 
with minimal cytotoxicity (Schmid et al., 2004). In that study, more indirect methods 
like assessing the phosphorylation state of AKT were used, whereas we directly 
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monitored PTEN´s substrate PI(3,4,5)P3 to determine the effect of these inhibitors in 
living cells. The bpV compounds have been used to study the involvement of PTEN in 
signaling, proliferation, apoptosis, and neurogenesis, (Band et al., 1997; Batty et al., 
2007; Tian et al., 2012; Becker et al., 2013) however, higher concentrations (200 nM – 
100 µM) were required. We found comparable concentrations to effectively inhibit 
PTEN activity in our live cell assay. Moreover, because the PTENCiV method is 
essentially a real-time approach in living cells, it can yield insights into the temporal 
cellular dynamics of PI(3,4)P2 and PI(3,4,5)P3 signaling that are difficult to obtain with a 
purely biochemical approach. As an example, we showed that down-regulation of 
PI(3,4,5)P3 (and PI(3,4)P2) concentration resulted in a surprisingly rapid switching-off of 
signaling by dephosphorylation of intermediates within the AKT signaling cascade, 
which (to our knowledge) has not been appreciated before. This finding points to a 
rather high activity of the protein phosphatase(s) that antagonize AKT kinase activity. 
In summary, this work established novel, simple to use, and broadly applicable 
methods that provide temporal control of VSPs. This allows for manipulation of PI 
levels and subsequently manipulation of their downstream targets. Moreover, using 
the engineered voltage sensitive enzyme PTENCiV we suggest a novel method for 
charactering this critical tumor suppressor in a population of living mammalian cells, 
fast and ingeniously. This method complements the already used in vitro and non-
mammalian PTEN activity assays and eases the study of this important tumor 
suppressor.  
4.3 Outlook 
In this thesis we extended our knowledge regarding several aspects of VSPs' function 
and regulation but many questions remain unanswered and further investigation is 
required to complete this work. 
In the first part of this thesis we demonstrated for the first time the pH dependence of 
VSPs' activity but the exact mechanism by which this occurs remains unknown. We 
speculated that the pH sensitivity observed affects the phosphatase activity, 
presumably by facilitating the catalysis. However we did not succeed in identifying the 
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histidine that plays the role of pH sensor. Of course other amino acids may also be able 
to sense pH changes, because the pKa values of amino acids in solutions often differ 
from the pKa values in a protein environment. For example amino acids with far from 
the physiological pKa values such as lysine, arginine and aspartic acid have been found 
to determine the pH dependence of proteins (Wragg and Drickamer, 1999; Niemeyer 
et al., 2010). To compute the pKa values of amino acids side chains in proteins several 
computation methods are available, for example the FDPB-based method (FDPB is for 
Finite Difference Poisson-Boltzmann) or molecular dynamics-based methods. This 
could facilitate the selection of possible candidates that act as pH sensors in VSPs. 
An alternative way to test the pH sensitivity of VSPs would be by in vitro phosphatase 
assays i.e. the malachite green phosphatase assay (Murata et al., 2005; Matsuda et al., 
2011), where we could estimate the efficiency of the phosphatase domain of VSPs to 
dephosphorylate soluble PI substrates at different pH conditions. This would allow the 
study of the pH influence without the involvement of parameters such as the sensing, 
kinases and pH domain binding, reassuring that pH directly affects the phosphatase. 
Another interesting question to be answered is if pH could directly activate VSPs. The 
data in section 3.1.3 provided evidence that pH can increase phosphatase activity 
during voltage activation. But can pH alone activate VSPs? This question is particularly 
relevant for hVSP1 which is expressed in testis and stomach, organs where voltage 
regulation is not straightforward. One way to test for this hypothesis would be to 
change in real time the intracellular pH value and simultaneous record the 
phosphatase activity. As shown in a study for pH sensitive TASK channels (Niemeyer et 
al., 2010) rapid intracellular acidification can be achieved using CO2-HCO3, while  
alkalization of the cell interior can be achieved with NH4Cl 
-.  
In the second part of this thesis we reported the development of a novel approach for 
studying the tumor suppressor PTEN, in living mammalian cells and without 
electrophysiology. In our experiments, we were able to analyze mutations and 
pharmacological inhibition of PTEN in a small population of cells. However, the 
technique might as well be used in high through-put mutation screens and screens for 
novel substances with pharmacological activity towards PTEN. As shown in Figure 3.14, 
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the phosphatase activity of VSPs can be monitored using a FRET-based system that is 
independent of translocation of PI sensors, and therefore independent from image 
analysis by the experimenter. Accordingly, the system for PTENCiV activation combined 
with an optimized FRET sensor can be employed for 96-well plates with automated 
solution exchange and automated fluorescence detection in standard multi-plate 
readers. 
In this work we contributed to increasing the understanding of some aspects of VSPs' 
function and regulation, as well as expanding their applicability as PI manipulating 
tools. Certainly, there is still a lot to learn about these fascinating “Janus Bifrons” 
(Villalba-Galea, 2012) proteins, first and foremost their physiological role in biological 
systems.  
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